Drug_NDC|Drug_cpa_description|Drug_cpa_url|Drug_cpa_EffDate|Drug_cpa_EndDate
00002143380|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00002143480|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00002144509|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00002144511|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00002144527|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00002322730|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00002322830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00002322930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00002323030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002323130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002323830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00002323930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00002325030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00002325130|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00002411230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002411530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002411630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002411730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002418230|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|06/25/2019|
00002418430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00002441530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002442030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002445385|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002445485|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002445585|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002445685|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002473230|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|06/25/2019|
00002759701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002763511|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002763611|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002763711|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00002771401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00002771459|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00002772401|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00002772411|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00002775205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00002814701|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00002814801|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00002814901|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00003089321|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00003089331|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00003089421|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00003089431|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00003089470|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00003218811|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00003218851|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00003281411|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00003281811|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00003376474|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00004005801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00004005801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00004006801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00004006801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00004009801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00004009801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00006000530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00006003330|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00006007861|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006007862|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006007882|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006008061|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006008062|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006008082|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006008131|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006008154|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006008182|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006011231|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006011254|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006022131|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006022154|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006027728|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006027731|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006027754|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006027782|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006032530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00006033530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00006046102|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
00006057561|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006057562|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006057582|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006057761|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006057762|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006057782|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006074731|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00006074754|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00006074931|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|01/19/2024
00006095154|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00006095231|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00006095254|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00006096031|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/14/2024
00006096054|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00006171131|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
00006386203|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
00006536703|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006536706|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006536803|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006536806|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00006927531|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
00008112312|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00009001201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00009002201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00009002901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009002901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009002902|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009002902|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009003101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00009004401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00009005501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009005501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009005503|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009005503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009005602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00009005604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00009005707|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009005707|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009005907|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009005907|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009006607|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009006607|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009006807|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009006807|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009007301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00009009001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009009001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009009004|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009009004|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009009401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00009009401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00009027101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00013215036|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00013262681|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013264681|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013264902|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013265002|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013265102|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013265202|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013265302|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013265402|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013265502|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013265602|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013265702|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00013265802|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00023350731|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00024540131|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00024542131|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00024550131|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00024552131|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00024574502|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|09/30/2023
00024574702|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|09/30/2023
00024576105|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00024585090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00024585130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00024585230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00024585530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00024585630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00024590801|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00024591001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00024591102|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017|
00024591401|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017|
00024591502|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017|
00024591801|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017|
00024591900|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017|
00024591902|Dupixent|https://paxpress.txpa.hidinc.com/dupixent.pdf|10/31/2017|
00024592001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00024592201|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00025101131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00025102131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/17/2023
00025138131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00025141160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00025141190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00025142160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00025151501|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00025151501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00025152031|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00025152031|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00025152034|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00025152034|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00025152051|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00025152051|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00025152531|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00025152531|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00025152534|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00025152534|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00025152551|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00025152551|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00025153002|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00025153002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00037200101|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
00037200101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00037225010|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
00037225010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00037601030|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|05/31/2023
00046074905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046087221|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110081|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110091|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110181|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110281|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110291|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110381|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110481|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110491|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110511|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110611|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00046110811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00049005460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00049392083|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00054001720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054001820|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054001825|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054001829|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054001920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054001925|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054006344|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|05/31/2024
00054008425|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00054008525|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00054008813|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
00054008826|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
00054017613|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
00054017613|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054017713|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
00054017713|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054018813|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00054018813|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054018913|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00054018913|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054023525|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054023525|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054023525|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054023625|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054023625|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054023625|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054023749|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054023749|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054023749|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054023763|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054023763|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054023763|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054023849|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054023849|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054023849|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054023863|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054023863|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054023863|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054024324|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054024324|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054024424|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054024424|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054024424|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054024425|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054024425|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054024425|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054024525|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054024525|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054024525|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054025413|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054025422|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054025513|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054025522|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054028325|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054028325|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054028325|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054028425|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054028425|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054028425|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054032656|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054032756|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054038663|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054038663|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054038663|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054039041|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054039041|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054039041|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054039063|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054039063|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054039063|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054039168|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054039168|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054039168|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054039268|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054039268|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054039268|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054050823|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023|
00054051741|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054051741|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054051741|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054051744|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054051744|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054051744|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054051750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054051750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054051750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054065025|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054065025|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054070920|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054070920|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054070920|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054070925|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054070925|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054070925|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054071020|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054071020|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054071020|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054071025|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054071025|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054071025|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054074287|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054300001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054300001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054300001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054306844|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00054306844|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054309036|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054309036|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054309036|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054317644|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054317757|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054317763|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054318544|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00054318544|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054318863|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00054318863|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054353244|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00054353244|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054354563|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054354563|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054354563|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054355344|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054355344|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054355344|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054355563|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054355563|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054355563|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054355663|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054355663|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054355663|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054363063|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054372144|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054372250|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054372263|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054417925|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054418025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054418125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054418225|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054418325|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054418425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054418625|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054453825|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00054453825|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054453825|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00054472825|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054472831|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054474125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054474131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054474225|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054485825|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00054485825|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054485925|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00054485925|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054485929|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00054485929|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00054817425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054817525|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054817625|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054817925|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054818025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054818125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054818325|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054872425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054873925|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054874025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054981725|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054981729|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054982825|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00054982831|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069019502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069019602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069020602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069021702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069022002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069022302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069022802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069023201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069033621|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
00069050130|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00069100101|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00069100201|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00069102902|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/30/2021|
00069130501|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
00069130510|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
00069130601|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
00069130610|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
00069130701|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
00069130710|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
00069130801|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
00069130810|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
00069130901|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
00069130904|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
00069215030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/03/2024
00069217030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|02/03/2024
00069218030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/27/2024
00069219030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069225030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/18/2024
00069226030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/27/2024
00069227030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/18/2024
00069322066|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069323066|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069419068|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
00069541066|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00069542066|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00071015523|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00071015623|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00071015723|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00071015823|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00071022323|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00071040124|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00071080324|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00071080524|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00071080624|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00071201244|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|07/12/2023
00071201247|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00074006702|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074012402|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074012403|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074012404|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074024302|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074055402|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074061602|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074081702|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074104328|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/03/2020|
00074105001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/04/2019|
00074107001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/04/2019|
00074153903|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074204202|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/04/2019|
00074210001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|11/04/2019|
00074230630|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/03/2020|
00074231030|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/03/2020|
00074254003|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074379902|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074433902|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074433906|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00074433907|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00075062040|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00075062160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00075062280|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00075062300|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00075062430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00075062603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00075291201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00075291501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078031434|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078031534|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078034542|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078034642|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078035415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00078035834|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078035934|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078036034|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078037005|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078037105|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078037205|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078038005|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078038105|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078038205|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078038334|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078042315|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078042405|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078043005|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078043105|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078043205|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078043305|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078043405|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078043905|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078044005|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078044105|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078047134|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078047234|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078048815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078048915|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078049015|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078049115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078049305|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078060805|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078060905|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00078063941|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00078063968|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00078063997|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00078063998|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00078065920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078065967|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078066419|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00078069620|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078069667|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078073461|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00078077720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078077767|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00078105697|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00085134102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00085433301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/31/2024
00093005801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093005801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093005801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093005805|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093005805|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093005805|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093007301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093007401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093030801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093031401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093031401|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012|
00093057610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093071101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093071105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093075601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093075701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093075705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093077198|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093092401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093092405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093092606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093092610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093092810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093094801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093094805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093100501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093100505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093100601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093100605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093111801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093112201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093171201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093171210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093171301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093171310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093171401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093171410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093171501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093171601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093171610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093171801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093172001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093172101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093172110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093172301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093192006|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
00093192006|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093192106|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
00093192106|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093206301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093309056|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00093309256|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00093309356|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00093309456|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00093312242|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093312298|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093313331|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012|
00093317431|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093321201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093321201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093321301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093321301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093321305|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093321305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093322308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093322397|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093323940|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093323940|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093324101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093324201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093324356|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093333406|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
00093342001|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
00093342001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342101|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
00093342101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342201|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
00093342201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342205|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
00093342205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342210|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
00093342210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093342501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342505|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093342505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093342510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093342601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342605|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093342605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093342610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093342701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093342705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093342710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093342710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093354143|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093354256|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093354356|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093354456|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093354556|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093354656|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093354756|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093354856|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093360782|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093360882|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093360982|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093365640|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093365640|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093365640|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093365740|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093365740|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093365740|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093365840|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093365840|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093365940|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093365940|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093365940|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093372755|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093406106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093406130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093414556|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093414656|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093414756|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093414856|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093500256|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093500356|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093500456|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093500556|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093500656|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093504501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093504601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093505610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093505698|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093505705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093505798|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093505810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093505898|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093505910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093505998|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093506001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093506005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093506101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093506105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093506110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093506201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093506205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093524565|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093524665|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093524765|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093524865|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093529201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093529301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093529501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093529601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093529701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093529801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093534601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093534701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093534801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093537601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093537701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093541601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093541701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093541784|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093541901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093541984|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093545528|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093545542|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093550356|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093550456|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093550556|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093550656|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093550756|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093551798|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
00093553756|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093553801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093553901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093555001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093555101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093555201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093555301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093555401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093556201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00093573101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093573101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093573101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093573101|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
00093573201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093573201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093573201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093573201|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
00093573301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093573301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093573301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093573301|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
00093573401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093573401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093573401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093573401|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
00093593898|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|04/05/2022|
00093593998|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|04/05/2022|
00093594098|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|04/05/2022|
00093595506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093595556|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093681555|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093681573|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093681655|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093681673|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093681773|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093716501|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00093716501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093716505|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00093716505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093716601|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00093716601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093716605|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00093716605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093717006|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00093717006|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093717201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093720110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093720198|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093720210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093720298|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093727010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093727098|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|02/09/2024
00093727105|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
00093727156|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
00093727198|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
00093727205|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
00093727256|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
00093727298|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
00093727305|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
00093727356|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
00093727398|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
00093729001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093729056|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093730606|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00093730606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093736710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093736756|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093736798|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093736810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093736856|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093736898|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093736910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093736956|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093736998|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093744201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093744256|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093744301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093744356|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093744601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093744656|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00093748756|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
00093751631|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093751731|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093751831|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093770198|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093786565|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00093786565|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093786565|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093786565|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093786665|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00093786665|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093786665|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093786665|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093786765|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00093786765|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093786765|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093786765|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093786865|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00093786865|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093786865|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093786865|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093786965|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00093786965|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093786965|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093786965|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093787065|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00093787065|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00093787065|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093787065|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00093810798|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093816201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093816301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093816401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093816501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093816601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00093823256|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093823298|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093823856|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093823898|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093922201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093922206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00093929067|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093929067|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093929167|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093929167|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093929267|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093929267|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093929367|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093929367|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00093929467|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00093929467|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00113005705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00113016626|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00113057826|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00113057826|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00113060471|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00113060478|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00113060490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00113061239|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00113061265|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00113066026|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00113089726|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00113089734|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115136529|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
00115136629|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
00115143613|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
00115143613|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00115143713|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
00115143713|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00115148361|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/22/2023
00115148601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115148701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115148801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115148901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115149001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115149101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115168774|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115168974|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115169606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115169701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115170001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115170901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115171001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115173601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115173701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115173801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115173901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115174001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115174101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115174501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00115174801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00115175701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115180001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115180101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115180201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115180301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115180302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115180401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115180402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115991801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115991901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115992001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115992101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115992201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00115993078|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115993178|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00115993278|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00121050404|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00121050404|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00121050416|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00121050416|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00121058104|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00121065304|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00121065402|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00121065416|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00121075908|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00121077001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00121077001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00121077204|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00121077204|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00121077204|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00121077216|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00121077216|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00121077216|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00121077308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00121077504|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00121077504|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00121077504|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00121077508|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00121077508|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00121077508|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00121077516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00121077516|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00121077516|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00121077708|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00121082508|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00121082508|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00121082508|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00121092716|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00121092716|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00121093304|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00121093304|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00121093304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00168041630|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00168041660|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00168041699|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00168041730|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00168041760|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00168041799|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00169291115|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00169406012|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00169406013|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00169517603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00169517604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00169770321|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00169770421|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00169770521|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00169770821|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00172208360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00172208380|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00172208960|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00172208980|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00172392560|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00172392560|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00172392570|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00172392570|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00172392660|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00172392660|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00172392670|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00172392670|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00172392680|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00172392680|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00172392760|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00172392760|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00172392770|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00172392770|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00172392780|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00172392780|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00173052100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00173060002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173060102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173060202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173068220|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173068224|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173069500|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173069600|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173069700|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173071520|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173071522|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173071620|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173071622|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173071720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173071722|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173071820|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173071920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173072020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173085910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173085914|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173086910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00173087410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173087610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173088210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173088710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173088714|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173088810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173089201|Monoclonal Antibody Agents  (Fasenra and Nucala)|https://paxpress.txpa.hidinc.com/Monoclonal%20Antibodies.pdf|04/06/2021|
00173089242|Monoclonal Antibody Agents  (Fasenra and Nucala)|https://paxpress.txpa.hidinc.com/Monoclonal%20Antibodies.pdf|04/06/2021|
00173089310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00173089314|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185002201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00185014101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185021101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185023601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185027701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185032501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185044801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00185067401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185067405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185067501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185067510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185067601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185067605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185068701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00185084201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00185085301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00185209801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00185209901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00186037020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00186037220|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00186091612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00186091706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00186198804|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00186198904|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00186199004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00187000402|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
00187014601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00187065820|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00187065920|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00187510001|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00187510102|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00187510203|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00228202710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228202710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228202750|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228202750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228202796|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228202796|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228202910|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228202910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228202950|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228202950|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228202996|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228202996|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228203110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228203110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228203150|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228203150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228203196|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228203196|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228203910|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228203910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228206710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00228206710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228206910|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00228206910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228207310|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00228207310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228207610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00228207610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228207650|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00228207650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228207710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00228207710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228207750|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00228207750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228234810|Propylthiouracil|https://paxpress.txpa.hidinc.com/ptu.pdf|04/18/2011|
00228255006|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00228255011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00228255096|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00228255106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00228255111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00228255196|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00228263611|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00228263650|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00228263711|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00228263750|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00228282011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00228285011|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228285111|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228285311|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228285511|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228305911|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228306011|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228306111|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228306211|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228306311|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228306411|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228308306|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228308306|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228308406|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228308406|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228308606|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228308606|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228308706|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228308706|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228309011|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228309011|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228309011|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00228309111|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228309111|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228309111|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00228309211|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228309211|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228309211|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00228309311|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228309311|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228309311|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00228311611|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228311611|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228311611|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00228311711|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228311711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228311711|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00228315303|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
00228315303|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228315403|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00228315403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228315503|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00228315503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228315567|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00228315567|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228315603|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
00228315603|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228350106|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|03/21/2023
00228350106|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/21/2023
00228350106|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|03/21/2023
00228401911|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228401911|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228402211|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228402211|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228402411|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228402411|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228402511|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00228402511|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228424106|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00228427011|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228427011|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228427011|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00228427111|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228427111|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228427111|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00228431111|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228431111|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228431111|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00228432311|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228432311|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228432311|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00228434711|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00228434711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00228434711|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00254302002|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
00254302102|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
00254302202|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
00254302802|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
00254302902|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
00310027110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310027210|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310027460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310027510|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310027810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310027910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310028060|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310028160|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310028260|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310028360|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310028460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00310075190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|05/09/2023
00310075590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|05/09/2023
00310183030|Monoclonal Antibody Agents  (Fasenra and Nucala)|https://paxpress.txpa.hidinc.com/Monoclonal%20Antibodies.pdf|04/06/2021|
00310460012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00310461612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00310461639|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00310610030|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00310610090|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00310610530|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00310610590|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00310612560|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00310613530|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00310614530|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00310654004|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00310661502|Symlin|https://paxpress.txpa.hidinc.com/symlin.pdf|01/31/2011|
00310662702|Symlin|https://paxpress.txpa.hidinc.com/symlin.pdf|01/31/2011|
00310678030|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00310737020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00310737220|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00310756090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00310757090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00310758090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00310759030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378004201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378007301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378021401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378021410|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378025701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378025710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378027101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00378027101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378027105|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00378027105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378032701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378032710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378033001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378033401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378033501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378034501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00378034501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378034505|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00378034505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378035101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378035110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378040301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378042401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378043401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378044201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378044501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378046001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2024
00378046401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2024
00378047701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00378047701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378047705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00378047705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378057401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378061201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378061401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378061601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378061801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378064001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378064010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378064101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378064110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378064201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378064205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378064210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378082501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378086001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378086005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378092393|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
00378092393|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378092493|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
00378092493|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378097201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378097301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378100101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|09/30/2023
00378107593|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378107693|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378107793|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378107893|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378113401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378113401|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012|
00378165777|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
00378172193|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378172293|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378172393|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378172493|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378200201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|10/31/2023
00378215001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378240101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378240201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378240501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378241001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378247401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/11/2023
00378292093|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378300001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378300177|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378300277|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378300377|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378300501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|10/31/2023
00378322477|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378322493|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378322577|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378322593|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378323177|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378323193|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378323277|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378323293|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378334999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378335099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378335199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378335299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378336099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378336199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378343193|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00378343293|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00378343393|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00378363501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378363701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378363705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378395005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378395077|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378395105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378395177|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378395205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378395277|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378395305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378395377|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378397893|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378397993|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378398093|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378398193|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378438591|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378438691|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378451493|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378451593|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378451793|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378451893|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378451993|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378461926|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378462026|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378462126|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378462226|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378462326|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378464026|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378464126|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378464226|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378464326|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378464426|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378501001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|10/31/2023
00378527001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00378527101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00378527201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00378551093|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378551193|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378551293|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378551393|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00378580793|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378581377|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378581477|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378581577|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378632177|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378632277|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378632377|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378632477|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378632577|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378699152|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/07/2023
00378699252|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/07/2023
00378699393|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378705752|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378705852|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378729453|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378729553|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378802077|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378802093|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378802177|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378802193|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00378820001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378826093|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00378826193|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00378826293|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00378826393|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00378827052|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378827091|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378876516|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00378876516|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378876593|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00378876593|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378876616|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00378876616|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378876693|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00378876693|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378876716|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00378876716|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378876793|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00378876793|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378876816|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00378876816|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378876893|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00378876893|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378877035|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378911998|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00378911998|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00378911998|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378911998|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00378912198|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00378912198|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00378912198|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378912198|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00378912298|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00378912298|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00378912298|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378912298|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00378912398|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00378912398|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00378912398|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378912398|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00378912498|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00378912498|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00378912498|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378912498|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00378912598|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00378912598|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00378912598|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378912598|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00378912698|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00378912698|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00378912698|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378912698|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00378912798|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00378912798|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00378912798|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00378912798|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00378932032|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378932132|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378932232|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378969052|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378969152|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00378969252|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00406012301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012310|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012310|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012362|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012362|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012362|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012410|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012410|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012462|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012462|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012462|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012562|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406012562|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406012562|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406012701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406013601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406015401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406037601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406037601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406037601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406037605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406037605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406037605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406037701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406037701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406037701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406037705|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406037705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406037705|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406037801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406037801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406037801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406037805|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406037805|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406037805|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406048301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406048301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406048301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406048401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406048401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406048401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406048410|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406048410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406048410|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406048462|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406048462|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406048462|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406048501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406048501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406048501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406048505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406048505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406048505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406051201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406051201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406051201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406051205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406051205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406051205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406052201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406052201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406052201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406052205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406052205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406052205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406052301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406052301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406052301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406052305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406052305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406052305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406052710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406052710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406052710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406054034|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406054034|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406054034|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406055201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406055201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406055201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406114201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406114401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406114601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406144501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406147301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406181001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406182001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406183001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406184001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406185001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406186001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406192303|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00406192303|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406254001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406254001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406254001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406324301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406324301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406324301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406324401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406324401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406324401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406324901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406324901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406324901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406575501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406575501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406575501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406577101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406577101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406577101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406800312|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406800312|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406800312|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406800315|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406800315|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406800315|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406800324|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406800324|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406800324|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406800330|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406800330|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406800330|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406800503|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00406800503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406802003|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00406802003|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406831501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406831501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406831501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406832001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406832001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406832001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406833001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406833001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406833001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406838001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406838001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406838001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406839001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406839001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406839001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406851501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406851501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406851501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406851562|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406851562|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406851562|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406853001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406853001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406853001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406853062|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406853062|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406853062|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406855605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406855605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406855605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406855730|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406855730|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406872510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406872510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406872510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406888401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406889301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406889401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406895801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406895901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406896001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406896101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406896201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00406900076|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406900076|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406900076|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406900076|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406901276|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406901276|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406901276|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406901276|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406902576|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406902576|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406902576|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406902576|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406905076|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406905076|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406905076|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406905076|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406907576|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406907576|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406907576|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406907576|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406920230|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406920230|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406920230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406920230|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406920430|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406920430|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406920430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406920430|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406920630|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406920630|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406920630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406920630|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406920830|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406920830|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406920830|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406920830|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406921230|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406921230|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406921230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406921230|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406921630|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
00406921630|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00406921630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406921630|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00406991403|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00406991403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406991501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00406991501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406991503|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00406991503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406991601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00406991601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406991701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00406991701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406995903|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00406995903|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00406996001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00406996001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00409113403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00409113403|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00409113405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00409113405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00409118130|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00409118130|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00409118130|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00409127303|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00409127332|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00409146301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00409146301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00409146301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00409146701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00409146701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00409146701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00409189001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00409189001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00409189101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00409189101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00409189201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00409189201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00409189301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00409189301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00409321311|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00409321312|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00409379601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00409379601|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012|
00409677802|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00409677802|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00430072024|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00430072124|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00430072224|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00430375414|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00456120130|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
00456120230|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
00456120330|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
00456240260|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00456240560|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00456241060|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00472103016|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00472103016|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00472103016|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00472178310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00472200294|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00480943589|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00485008001|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00485008001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00485009816|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00485015516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00485015516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00485017116|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00485017116|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00485017116|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00485020216|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00485020216|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00485020404|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00485020404|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00485020404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00485020416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00485020416|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00485020416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00485020616|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00485020616|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00485020816|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00485024001|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00485024001|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00485024001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00485025401|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00485025401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00487020101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00487020103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00487020160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00487030101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00487950101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00487950103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00487950125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00487950160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00487990130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00487990401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00487990425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00517042001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00517044001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00517176701|Makena|https://paxpress.txpa.hidinc.com/makena.pdf|06/12/2015|04/07/2023
00517420125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527131201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00527131201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00527131201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00527135301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00527135301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00527135301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00527135401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00527135401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00527135401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00527135501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00527135501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00527135501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00527139401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00527139501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00527139601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00527139701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00527143501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00527150037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527150137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527150237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527150337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527150437|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527150537|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527150637|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527163201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527163210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527176836|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00527176836|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00527178801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00527178901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00527179001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00527179005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00527179101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00527179105|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00527194947|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527217037|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527293037|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527293043|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527293137|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527293237|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527293243|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527293337|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527293341|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527293437|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527293441|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527293537|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527331037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|10/25/2023
00527331137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|10/25/2023
00527331237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|10/25/2023
00527331337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|10/25/2023
00527457937|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527458037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527458137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527458237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527458337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527458437|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527530264|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00527530264|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00527530264|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527530270|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00527530270|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00527530270|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00527551037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527551137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527551237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527551337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527551437|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527551537|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527810637|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527810737|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527810837|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527810937|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527811037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527811137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527811237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00527811337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00536100601|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536100601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536100610|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536100610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536101001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536109301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/22/2023
00536109306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536109401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536109411|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536114730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536116134|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536116134|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00536116137|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536116137|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00536116361|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536118297|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536118497|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|06/20/2023
00536118497|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|06/20/2023
00536121388|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536121388|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00536121429|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536124207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536125775|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/30/2024
00536127912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536127935|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536129431|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|06/30/2023
00536129434|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536129497|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536129701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536129710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536129910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00536130907|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536130908|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536131108|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536131208|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536131208|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00536131385|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536131385|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00536131485|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536133321|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536133336|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536133434|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00536133434|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00548560100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00548560200|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00548560300|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00548560400|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00548560500|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00548560600|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00548560700|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555003302|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00555003302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00555003305|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00555003305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00555015802|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00555015802|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00555015804|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00555015804|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00555015902|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00555015902|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00555015904|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00555015904|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00555030202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555030204|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555032302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555032304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555032402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555048302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555048305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555077502|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00555077602|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00555077702|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00555088602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555088604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555088702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555088704|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555089902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00555095202|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00555095302|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00555097102|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00555097202|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00555097302|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00555097402|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00574022701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00574022801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00574022901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00574024001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00574024101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00574024201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00574110404|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00574110404|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00574110404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00574110416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00574110416|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00574110416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00574206727|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00574704012|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00574704012|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00574704012|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00574704512|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00574704512|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00574704512|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00574722406|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00574722406|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00574985510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591034701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591034705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591034801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591034805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591034810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591036901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591037001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591037101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591037201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591039501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00591039501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591039501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00591039719|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591039760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591039860|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591042401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591042405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591074401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00591074401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591074501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00591074501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591086001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591086005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591086101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591086105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591086201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591086205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591219101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00591219130|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00591234101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591246401|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|02/06/2024
00591246501|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|02/06/2024
00591252001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591252005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591264101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591264101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00591269301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00591269301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591269301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00591269301|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
00591270801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00591270801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591270801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00591270801|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
00591292754|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591294430|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00591294460|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00591294487|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
00591322001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00591322001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591322001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00591335501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591346753|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591346853|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591354601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00591354601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591354601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00591354605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00591354605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591354605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00591367001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591367005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591367101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591367105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591369230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591369319|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591369330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591369419|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591369430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591369519|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591369530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591385419|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00591386219|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00591386919|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00591387319|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00591389119|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00591389519|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00591390219|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00591398260|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00591398260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00591398301|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00591398301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00591398305|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00591398305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00591398401|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00591398401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00591398405|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00591398405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00591405094|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015|
00591410101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591410201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591410301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591410401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00591505201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591505210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591530701|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00591530710|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00591531901|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00591544201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591544205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591544210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591544301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591544305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591544310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591551301|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
00591551301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591551305|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
00591551305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591551310|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
00591551310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00591566001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591566005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591566101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591566105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591578201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00591578301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00597002402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00597002901|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|04/01/2023
00597002901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|04/01/2023
00597003937|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00597004037|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00597004137|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00597004237|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00597004337|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00597004437|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00597014030|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597014090|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597014618|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597014660|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597014718|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597014760|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597014818|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597014860|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597015561|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00597015570|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00597016430|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597016490|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597018230|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597018239|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597018290|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597019261|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00597027073|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597027094|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597027533|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597027581|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
00597035509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00597035556|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00597036055|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00597036082|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603255321|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|09/30/2023
00603255321|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|09/30/2023
00603255321|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|09/30/2023
00603358621|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|05/31/2023
00603358621|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/31/2023
00603358621|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/31/2023
00603358621|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/31/2023
00603388728|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00603388728|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00603388728|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00603388732|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00603388732|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00603388732|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00603389028|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|11/30/2023
00603389028|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|11/30/2023
00603389028|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|11/30/2023
00603389032|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|11/30/2023
00603389032|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|11/30/2023
00603389032|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|11/30/2023
00603389128|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|11/30/2023
00603389128|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|11/30/2023
00603389128|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|11/30/2023
00603389132|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|11/30/2023
00603389132|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|11/30/2023
00603389132|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|11/30/2023
00603459315|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603459321|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603506021|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00603506121|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00603506128|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00603506221|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00603506228|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00603506321|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00603533521|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533532|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533621|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533721|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533731|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533732|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533821|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533828|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533831|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533832|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533921|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533928|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00603533932|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00641092821|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00641092825|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00641092921|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00641092925|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00641094931|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00641094935|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00641139835|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00641149535|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00641149635|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00641605225|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00641605225|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00641605225|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00641605325|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00641605325|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00641605325|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00641605425|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00641605425|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00641605425|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00641608425|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00703001801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00703001801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00703001801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00703011003|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00703011003|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00703011003|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00703011303|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00703011303|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00703011303|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00703505103|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
00703505401|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
00713013212|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00713052612|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00713053612|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00781106101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781106101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781106105|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781106105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781106110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781106110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781107701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781107701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781107705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781107705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781107710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781107710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781107901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781107901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781107905|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781107905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781107910|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781107910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781108901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781108901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781108905|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
00781108905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781183001|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00781183010|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|09/30/2024
00781183201|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00781207401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781207410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781208102|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
00781216460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781216660|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781216760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781216860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781232106|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
00781232151|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
00781232246|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
00781232268|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
00781232368|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
00781232901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00781233501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00781234301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00781235201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00781236101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00781236201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00781236301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00781236401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00781236801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00781237101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00781300107|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00781300407|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00781315972|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781323863|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781324664|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781325666|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781326268|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781326869|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781329868|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781329969|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781344395|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781345495|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781346595|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781347612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781347695|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781400436|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
00781406336|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
00781502201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781502207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781531501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00781531601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00781531701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00781531710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00781531801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00781531810|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00781540092|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00781540292|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|05/31/2023
00781540331|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00781710454|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781711954|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781712254|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781712983|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781713354|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781713454|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781713654|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781713883|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781714483|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781715683|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781716783|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781721606|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00781721606|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781721664|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00781721664|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781722706|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00781722706|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781722764|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00781722764|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781723806|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00781723806|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781723864|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00781723864|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781724906|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00781724906|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781724964|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00781724964|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00781729685|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781751587|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781751687|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781751787|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00781801701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00781801731|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00781802801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781802931|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00781803201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781803401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781803601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781803731|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00781804531|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00781804601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781804701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781804801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781804901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00781805331|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
00781910572|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832022500|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00832022500|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00832022500|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00832022600|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00832022600|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00832022600|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00832022700|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00832022700|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00832022700|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00832022800|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00832022800|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00832022800|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00832022900|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00832022900|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00832022900|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00832023000|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00832023000|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00832023000|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00832023300|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00832023300|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00832023300|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00832027311|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00832027311|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00832027311|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00832027411|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00832027411|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00832027411|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00832030000|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832030100|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832030110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832030200|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832030210|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832030300|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832030310|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832030400|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832030410|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832105410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00832121100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121200|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121300|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121400|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121500|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121600|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121700|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121800|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121900|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832121901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00832151011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832152011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832153011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832154011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832155011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832156011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832601700|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832601800|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832601810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832601901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832602001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832602101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00832602110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904001280|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904001280|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904025024|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|10/10/2023
00904025024|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/10/2023
00904025059|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|11/22/2023
00904025059|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/22/2023
00904530624|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904530660|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/27/2023
00904530680|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/31/2024
00904530760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904530780|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904530909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904530920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904557720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904578624|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00904583315|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904583348|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904585340|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904585360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904585440|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904585461|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904585540|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904585560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904585561|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904589161|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904589261|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904589361|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904600760|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00904600760|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904600761|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00904600761|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904600860|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00904600860|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904600861|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00904600861|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904600960|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00904600960|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904600961|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00904600961|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904608261|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00904621740|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904626908|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904627008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904627108|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904627208|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904628361|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904628606|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904628661|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904628706|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904628761|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904629061|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904629161|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904629261|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904629304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904631256|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904631256|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00904635761|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904635861|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904635961|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904636061|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904636161|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904636261|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904637661|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904637761|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904643604|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00904643604|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904646161|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
00904646320|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904646320|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00904646320|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904646420|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|08/05/2023
00904646420|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|08/05/2023
00904650261|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00904650261|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904650361|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
00904650361|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904650904|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904651006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904651061|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904651106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904651161|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904651204|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904651304|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904651404|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904651661|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904651761|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904653061|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00904653061|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904653061|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00904653720|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904653720|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00904655761|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00904655761|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904655761|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00904655861|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00904655861|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904655861|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00904655961|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00904655961|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904655961|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00904656061|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00904656061|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904656061|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00904656460|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904656461|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|12/27/2023
00904659961|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904660061|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904660161|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904661761|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904661861|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904663861|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904663961|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904664061|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904664161|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904664261|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904664361|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904665640|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904666561|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00904666661|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00904666761|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
00904667104|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
00904667840|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
00904667840|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904667840|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
00904671146|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904671740|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904671741|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904671743|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904671746|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904671760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904671761|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904671772|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904671786|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904671839|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904674724|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904674740|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904674751|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904674759|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904674770|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904674780|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904675859|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|07/05/2023
00904675859|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|07/05/2023
00904676130|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904676320|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904676520|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904676720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904677861|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904678061|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
00904680361|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904680561|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
00904680861|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
00904683106|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904685207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904685260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904685261|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904685272|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904685289|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904690804|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
00904698516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904698520|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904698640|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904699544|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00904699644|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00904700635|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904700906|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00904700906|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904701006|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
00904701006|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904705040|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904705060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904715404|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
00904715404|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904715504|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
00904715504|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
00904719240|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904719260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904722320|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904722320|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00904722359|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
00904722359|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
00904723724|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904723760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904723780|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904791251|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00904791459|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00944417910|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
00955100310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955100410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955100610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955100810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955101010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955101210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955101510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955101601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955104090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955104190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955104290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955104590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955104690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
00955104818|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
00955105027|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
00955105290|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
00955105490|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
00955170210|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
00955170310|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
10122010150|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
10122050201|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
10147068501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|01/16/2024
10147068601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|01/16/2024
10147068701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|01/16/2024
10147068801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|01/16/2024
10147095103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|01/16/2024
10147095203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|01/16/2024
10147095303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|01/16/2024
10147095403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|01/16/2024
10370011610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
10370011710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
10370025702|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702000201|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
10702000301|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
10702000310|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
10702000401|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
10702000601|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
10702000601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702000610|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
10702000610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702000650|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
10702000650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702000701|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
10702000701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702000710|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
10702000710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702000750|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
10702000750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702000801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702000801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702000801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702000850|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702000850|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702000850|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702000901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702000901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702000901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702000950|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702000950|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702000950|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702001001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
10702001050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
10702001101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
10702001110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
10702001150|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
10702001201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
10702001210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
10702001250|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
10702001801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702001801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702001801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702001850|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702001850|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702001850|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702002301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702002301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702002301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702005501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
10702005501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702005501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702005503|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
10702005503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702005503|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702005601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702005601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702005601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702005650|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702005650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702005650|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702005701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702005701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702005701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702005750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702005750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702005750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702006501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702006601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702007001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702007001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702007001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702007006|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702007006|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702007006|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702007101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702007101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702007101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702007106|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702007106|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702007106|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702007501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702007601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702010001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702010101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702010201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702010601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702010701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702010801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702015016|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
10702015016|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702015016|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702016350|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702016450|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
10702018401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702018401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702018401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702018501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702018501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702018501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702018601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702018601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702018601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702018701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702018701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702018701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702018750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702018750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702018750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702018910|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702018910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702018910|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702018950|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702018950|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702018950|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702019001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702019001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702019001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702019010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702019010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702019010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702019050|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702019050|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702019050|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702019101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702019101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702019101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702019150|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702019150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702019150|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702019201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702019201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702019201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702019301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702019301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702019301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702019401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702019401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702019401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702034301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702034301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702034301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702034401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702034401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702034401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
10702034501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
10702034501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
10702034501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
11534018801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
11534018901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
11534019001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
11534019101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
11534019201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
11534019301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
11534019401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
11534019501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
11534019601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
12496009001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
12496012001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
12496120201|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
12496120201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
12496120203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
12496120203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
12496120401|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
12496120401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
12496120403|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
12496120403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
12496120801|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
12496120801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
12496120803|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
12496120803|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
12496121201|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
12496121201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
12496121203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
12496121203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
12830076216|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
12830076216|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
12830081616|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
12830081616|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
12830081616|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13107000401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13107000401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107000401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107000401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107001901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107001901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107001901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107001905|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107001905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107001905|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107002001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107002001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107002001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107002005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107002005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107002005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107002101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107002101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107002101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107002105|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107002105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107002105|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107002199|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107002199|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107002199|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107003501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13107003601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13107004401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107004401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107004401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107004405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107004405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107004405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107004501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107004501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107004501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107004505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107004505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107004505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107004601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107004601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107004601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107004605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107004605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107004605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107005501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107005501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107005501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107005601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107005601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107005601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107005701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107005701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107005701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107005801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107005801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107005801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107005901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107005901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107005901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107005999|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107005999|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107005999|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107006001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107006001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107006001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107006005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107006005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107006005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107006099|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107006099|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107006099|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107006801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13107007001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13107007201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13107007301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13107007401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13107008301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107008301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107008305|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107008305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107008401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107008401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107008405|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107008405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107008499|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107008499|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107008501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107008501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107008801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107008801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107008801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107008901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107008901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107008901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107010301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107010301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107010301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107010401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107010401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107010401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107010701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107010701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107010701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107010801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107010801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107010801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107010901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107010901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107010901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107021101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107021101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107021101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107021105|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107021105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107021105|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107021201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107021201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107021201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107021205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107021205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107021205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107021301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107021301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107021301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107021305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13107021305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107021305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13107031901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107031901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107031905|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107031905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107032001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107032001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107032005|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107032005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13107032101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13107032101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13668000701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13668000705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13668000710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13668000801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13668000805|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13668000810|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
13668003505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668003560|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668003605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668003660|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668003705|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668003760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668003805|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668003860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668003905|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668003960|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668004005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668004060|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668006730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668006890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668006990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668007090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668007905|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
13668007930|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
13668007990|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
13668008005|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
13668008030|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
13668008090|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
13668008190|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
13668008630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668008830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668008930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668009030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668011310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668011905|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668011930|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668011990|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668012005|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668012030|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668012090|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668014005|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668014030|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668014090|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668015630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668015730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668015830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668015930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668016030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668016130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668016630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668016730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668016830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668016930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668017030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668017130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668017905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
13668017990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
13668018090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
13668018190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
13668018205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
13668018230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
13668018590|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
13668021630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668021690|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668021730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668021790|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668021830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668021890|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668021930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668021990|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668022030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668022090|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668022130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668022190|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668024830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668024890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668024930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668024990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668025030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668025090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668025130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668025190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668025230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668025290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668025330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668025390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668028033|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668028060|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668028133|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668028160|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
13668031130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668031190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668031230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668031290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668031330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668031390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668032430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668032490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668034330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668034430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668034530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668034630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668038230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668038530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668038630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668039730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668040910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668040930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668040990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13668044101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
13668044101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
13668053194|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
13668057710|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
13668057710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13668057710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13668058130|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
13668058906|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
13668059607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
13811068930|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13811068930|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13811068930|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13811069030|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13811069030|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13811069030|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13811069130|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13811069130|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13811069130|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13811070110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13811070110|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13811070210|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13811070210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13811070210|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13811070310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13811070310|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13811070410|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
13811070410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13811070410|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
13811070610|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13811070710|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13811070810|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13811070910|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
13811071710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13811071810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
13925016604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
14539067301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
14539067306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
14539067401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
14539067405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
14539067501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
14539067505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
15054104005|Increlex|https://paxpress.txpa.hidinc.com/increlex.pdf|01/31/2011|
15370013010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
15370017030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
15370018060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571020106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571020110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571020111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571020150|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571020206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571020210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571020211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571020310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571040110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571040210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571040250|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571066001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571066050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571066101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571066110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571068809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571071601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
16571071601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571071601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
16571071610|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
16571071610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571071610|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
16571071650|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
16571071650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571071650|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
16571071701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571071710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571071801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571071810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571071901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571071910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571072001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571072010|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571072106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571072110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571072201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571072250|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16571072501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571072601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571072701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571073927|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
16571075809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571075909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571078001|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
16571078001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571078101|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
16571078101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571078110|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
16571078110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571078150|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
16571078150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571078201|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
16571078201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571078210|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
16571078210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571078250|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
16571078250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571078301|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
16571078301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571078310|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
16571078310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571078350|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
16571078350|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16571080501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571081320|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
16571082201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571082203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16571082230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714000610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714001501|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|05/31/2024
16714001610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714001830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714001930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714002030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714002610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714003610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714004610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714004701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714004801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714004901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714005001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714005101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714005610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714006610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714008110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714008111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714008210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714008211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714008212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714008310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714008311|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714009425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2023
16714009430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2023
16714009525|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2023
16714009625|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2023
16714014101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714014201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714014301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714014401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714014501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714014601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714017301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714017603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714019001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714019101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714019201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714019301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714021301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714021302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714021303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714033001|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
16714033002|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
16714033201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
16714033202|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
16714045201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714045202|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714045301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714045302|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714045401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714045402|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714045501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714045601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714045701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714049701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714049702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714049801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714049802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714049901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714049902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714051001|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|02/29/2024
16714051001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|02/29/2024
16714055901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714056001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714056002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714057002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714062101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
16714062102|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
16714062201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
16714062202|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
16714066101|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
16714066102|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
16714066201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
16714066202|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
16714066302|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
16714067201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714067301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714067401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714067402|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714067501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714067502|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714068101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714068503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714073101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
16714073101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714073201|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
16714073201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714073202|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
16714073202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714073301|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
16714073301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714073302|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
16714073302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714073401|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
16714073401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714075501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714075601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714075701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714075801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714075901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714076001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714076101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714077801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714077802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714077901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714077902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714078001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714078002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714078101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714078102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714078501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|10/31/2023
16714079901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714079902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714079903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714079904|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714080501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714080801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714081401|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
16714082101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714082201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714082301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714082901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714083501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714083601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714083701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714083801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714086601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714086701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714086801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714086901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16714087403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|04/30/2023
16714087502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|03/31/2023
16714087503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|03/31/2023
16714087601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|03/31/2023
16714087602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|04/30/2023
16714087603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|03/31/2023
16714087701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|03/31/2023
16714087702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|03/31/2023
16714087703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|03/31/2023
16714088301|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
16714088401|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
16714089101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714089801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714089802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714089803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714089901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714089902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714093601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714093701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16714094801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714094901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714095001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714095201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714095301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16714095401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|12/31/2023
16714098801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714098901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714099001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16714099101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000417|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000517|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000617|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000717|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000816|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000915|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000916|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729000917|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729001015|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729001016|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729001017|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729001115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729001116|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729002015|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
16729002016|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
16729002115|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
16729002116|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
16729002215|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
16729002216|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
16729004415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729004417|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729004515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729004517|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729004615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729004617|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729004715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729004716|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729009512|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729009612|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729009712|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729010912|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729011910|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
16729011915|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
16729011917|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
16729013212|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729013600|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
16729013600|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16729013616|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
16729013616|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16729013700|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
16729013700|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16729013716|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
16729013716|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16729013800|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
16729013800|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16729013816|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
16729013816|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16729014101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014116|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014216|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014517|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014617|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014717|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014817|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014912|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729014917|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729015001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729015016|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729015615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729018201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729018217|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729018301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729018317|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729018401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729018417|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729027801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729027810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729027901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729027910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729028001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729028010|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729028101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729028110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729028201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729028210|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729028301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729028310|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
16729028415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729028417|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729028515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729028517|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729028615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729028617|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729028710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729028715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729028717|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
16729032110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729032115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729032117|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729032210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729032215|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729032217|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729036615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729036715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729036815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
16729042101|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
16729042110|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
16729042112|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
16729042201|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
16729042210|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
16729042212|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
16729047801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16729047901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16729048001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
16729054910|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
16729054910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
16729055010|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
16729055010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
17478017224|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
17478017324|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
17478017424|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
17772013130|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/26/2022|
17772013230|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/26/2022|
17772013330|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/26/2022|
21724070105|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
21922000909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155000810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155000910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155002101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155002201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155048901|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
23155049001|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
23155050001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155050005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155050010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155050101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155050105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155050110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155050201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155050205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155053102|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
23155060403|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
23155060409|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
23155060503|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
23155060509|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
23155062102|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
23155070301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23155079901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
23155080001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
23155080101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
23155080201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
23155080801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
23155084012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23359003216|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
23359003216|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23594010105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
23594050501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/15/2023
23635058110|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
23635058110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
23635058110|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
23635058210|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
23635058210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
23635058210|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24338002210|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/02/2023
24338002610|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/02/2023
24338003101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019|
24338003301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019|
24338003501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019|
24338003702|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019|
24338085003|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24338085010|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/13/2023
24338085103|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24338085110|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/02/2023
24338085203|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24338085210|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/13/2023
24338085303|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24338085310|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/02/2023
24338085403|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24338085410|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/13/2023
24338085503|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24338085510|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/13/2023
24338085603|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24338085610|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/13/2023
24385035926|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
24385035926|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
24385035934|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
24385035934|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
24385047199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
24385053126|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
24385060471|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
24385060478|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
24385064771|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
24385064778|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
24385099865|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
24385099875|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
24478007401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24478007501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24478007601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24478010201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017|
24478032102|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24478032204|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24478032305|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24478032406|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24510005010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510005010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510005010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510005860|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510005860|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510005860|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510007510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510007510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510007510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510010010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510010010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510010010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510011010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510011010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510011010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510011010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
24510011510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510011510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510011510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510011510|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
24510011660|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510011660|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510011660|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510012010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510012010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510012010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510012010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
24510013010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510013010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510013010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510013010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
24510014010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510014010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510014010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510014010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
24510017460|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510017460|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510017460|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510023260|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510023260|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510023260|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24510029160|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
24510029160|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24510029160|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
24979003504|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
24979003504|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24979003604|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
24979003604|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
24979018646|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
24979053301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24979053401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24979053601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
24979053801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
25208020109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
25208020209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
25682001012|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|06/30/2021|
25682001312|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|06/30/2021|
25682001612|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|06/30/2021|
25682001912|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|06/30/2021|
27241000106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000150|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000250|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000350|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000406|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000450|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000506|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000550|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000606|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241000650|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241001531|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
27241005103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005108|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005208|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005308|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005408|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005508|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241005608|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27241008303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27241008309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27241008403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27241008409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27241008503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27241008509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27241008603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27241008609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27241010806|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
27241011105|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
27241011205|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019|
27241011305|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
27241011405|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
27241012302|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
27241012403|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
27241012502|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
27241012602|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
27241017529|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015|
27808000201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27808003501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808003501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808003501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808003502|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808003502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808003502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808003503|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808003503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808003503|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808003601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808003601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808003601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808003602|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808003602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808003602|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808003603|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808003603|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808003603|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808003701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808003701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808003701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808003702|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808003702|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808003702|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808003703|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808003703|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808003703|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808005102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27808005102|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
27808005701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
27808005701|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
27808005701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27808005701|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
27808005801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
27808005901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
27808006502|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
27808006502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27808006502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808006502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808006502|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
27808008201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808008201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808008201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808008202|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808008202|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808008202|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808008501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
27808008601|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
27808008601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27808008601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808008601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808008602|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
27808008602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
27808008602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808008602|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808009101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
27808009201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
27808009301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
27808010201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017|09/19/2023
27808011401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808011401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808011401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808011402|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808011402|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808011402|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808011501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808011501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808011501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808011502|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808011502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808011502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808011601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808011601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808011601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808011602|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
27808011602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
27808011602|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
27808015501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
27808015503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
27808015601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
27808015603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
27808015701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
27808015703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
27808015801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
27808015803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
27808022201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27808022301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27808022401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
27808022501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
28595080130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
28595080208|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
28595080316|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
28595080316|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
28595080416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
28595080416|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
28595080416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
28595090060|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
28595090060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29033001201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29033001301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29033002602|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
29033020701|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
29033020701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29033040535|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
29033040535|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29033040535|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
29300012401|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
29300012401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
29300012410|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
29300012410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
29300012501|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
29300012501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
29300012510|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
29300012510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
29300012801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300012810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300012901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300012910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300013001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300013005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300013010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300013101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
29300013201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
29300014519|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300014701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
29300014710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
29300014801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
29300014810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
29300014901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
29300015001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
29300015101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
29300015116|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
29300015201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
29300018701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300018705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300018713|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300018801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300018805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300018813|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300018901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300018905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300018913|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300019010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300019019|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300019110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300019119|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300019210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300019219|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300022010|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
29300022013|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
29300022019|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
29300022110|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
29300022113|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
29300022119|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
29300022210|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
29300022213|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
29300022219|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
29300025501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300025601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300028613|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
29300028705|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019|
29300028713|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019|
29300028813|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
29300028913|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
29300035501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
29300035501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29300035501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
29300035505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
29300035505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29300035505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
29300035510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
29300035510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29300035510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
29300040001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300040101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
29300041301|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
29300041301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29300041305|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
29300041305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29300041319|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
29300041319|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29300041401|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
29300041401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29300041501|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
29300041501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29300041510|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
29300041510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
29300041519|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
29300041519|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722000760|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
31722000860|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
31722010901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722010901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722010901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722010901|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
31722011001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722011001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722011001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722011001|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
31722011101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722011101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722011101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722011101|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
31722011901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722011901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722012001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722012001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722012001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722012101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722012101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722012201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722012201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722012201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722013631|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015|
31722015130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722015290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722015390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722015490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722015501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722015601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722015701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722015801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722015901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722016301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722016401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722016601|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
31722016605|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
31722016701|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
31722016705|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
31722017301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722017401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722017501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722018501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722018601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722018701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722018801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722018901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722019205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722019205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722019205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722019301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722019301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722019301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722019305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722019305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722019305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722019401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722019401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722019401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722019501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722022901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722023001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722023101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722023201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722023301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722023401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722023501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722023601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722053301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722053305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722053401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722053405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722054201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722054301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722055190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722056501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722056560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722062160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722062260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722064730|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
31722065931|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722070005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722070010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722070090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722070110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722070130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722070190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722070210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722070230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722070290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722071430|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722071530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722071630|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722071730|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722071830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722071930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722072030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722072610|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
31722072630|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
31722072690|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
31722072730|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
31722072790|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
31722072830|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
31722072890|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
31722072930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722072990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722073030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722073090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722073130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722073190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722074530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722074690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722074790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722074890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
31722077605|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
31722077690|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
31722081930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
31722082030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
31722082111|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
31722082211|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
31722082730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
31722082830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
31722082930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
31722083030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
31722088290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
31722088390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
31722088490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
31722088530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
31722091701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722091701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722091701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722091705|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722091705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722091705|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722091801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722091801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722091801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722091805|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722091805|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722091805|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722092601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722092701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722092801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722092901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722092901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722092901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722093001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722093001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722093001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722093612|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012|
31722094101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722094101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722094101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722094105|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722094105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722094105|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722094201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722094201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722094201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722094205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722094205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722094205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722094301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722094301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722094301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722094305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722094305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722094305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722094601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722094601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722094601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722094701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722094701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722094701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722094801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722094801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722094801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722094901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722094901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722094901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722095005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722095005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722095005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722095101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722095101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722095101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722095105|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722095105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722095105|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722095201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722095301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722095401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722095501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
31722095801|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
31722099601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722099601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722099601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722099605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722099605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722099605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722099701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722099701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722099701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
31722099705|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
31722099705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
31722099705|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
33342004707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342004710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342004807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342004810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342004907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342004910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342005007|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342005044|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342005107|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342005144|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342005207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342005407|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342005410|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342005415|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342005507|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342005510|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342005515|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342005607|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342005610|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342005615|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342005707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342005710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342005807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342005810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342006207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342006310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342006410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342006510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342006707|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342006744|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342006807|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342006844|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342006907|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342006944|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342007007|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342007015|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342007107|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342007115|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342007207|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342007215|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342007410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342007444|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342007510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342007515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342007610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342007615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342007710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342007715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342007810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342007815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342008307|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342008311|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342008407|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342008411|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342008507|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342008511|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342008607|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342008611|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342009911|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342010011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342010111|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342010207|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
33342010210|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
33342010215|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
33342010311|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342010511|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342011007|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
33342011010|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
33342011107|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
33342011110|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
33342011407|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342011507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342011607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342011610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342011707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342011710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342012110|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
33342012207|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342012307|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342012407|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342012507|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342012607|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342012707|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342013110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342013115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342013210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342013215|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342013310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342013315|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342014409|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342014509|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342014609|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342014709|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
33342015509|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
33342015509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
33342015711|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
33342015711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
33342015715|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
33342015715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
33342015809|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
33342015809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
33342017609|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342017657|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342017709|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342017757|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
33342017807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342017907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342017910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342018007|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342018010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342019007|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342019010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342019107|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342019110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342019207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342019210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342019307|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342019310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342020010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
33342020144|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
33342020144|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
33342020144|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
33342029907|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
33342030011|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
33342030111|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
35356055630|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
35356055630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
35573041302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
35573041304|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
35573041530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
35573041630|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
35573041730|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
35573041830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
35573041930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
35573042030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
35573042130|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
35573043602|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
35573043702|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
35573043802|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
35573043902|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
35573044002|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
35573044102|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
35573044202|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
35573044325|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
35573044425|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
35573044525|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
35573045002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
35573045002|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012|
42023011001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42023011101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42023011201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42192060704|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
42192060704|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
42192060704|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42192060716|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
42192060716|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
42192060716|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42192060816|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
42192061701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
42192061705|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
42192061805|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
42192061916|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42195010090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|08/05/2030
42195012106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42195015110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42195030809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/05/2030
42195047101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42195084010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|08/15/2045
42195084010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|08/15/2045
42195084010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|08/15/2045
42291017430|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
42291017430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42291017530|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
42291017530|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42292002620|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|11/30/2023
42292002720|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|09/30/2023
42494040901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42494042510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42494042810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42543000510|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|03/31/2023
42543000590|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|03/31/2023
42543011401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2023
42543011501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2023
42543014050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42543014101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42543014201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42543070001|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|03/31/2023
42543070001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/31/2023
42543070005|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|03/31/2023
42543070005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/31/2023
42543070010|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|03/31/2023
42543070010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/31/2023
42543071290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2023
42543096407|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42543096507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42543096607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571011010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571011110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571011210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571011901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42571011901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42571011901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42571011905|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42571011905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42571011905|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42571012290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571013360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571014260|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42571014260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571014301|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42571014301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571014305|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42571014305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571014401|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42571014401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571014405|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42571014405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571014560|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42571014560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571017210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571017290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571017310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571017390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571017410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571017490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571017510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571017590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42571017601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571017701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571020230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571020290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571020330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571020390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571022630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571022730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571022830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571023530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571023590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571023630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571023690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571023730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571023790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571023830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571023890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42571025830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42747072601|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
42794001610|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
42794001710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
42799011101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799011201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799021701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42799021701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42799021702|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42799021702|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42799081201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799081301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799092001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799092002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799092030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799092101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799092102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799092130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799092201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799092202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42799092230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806000501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42806000501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42806000501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42806000601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42806000601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42806000601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42806000701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42806000701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42806000701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42806000801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42806000801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42806000801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42806000901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42806000901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42806000901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42806001101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806001105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806001201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806001210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806001401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806001410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806001801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806001805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806005030|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42806005030|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42806005030|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42806008701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806008705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806008801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806008805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806008901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806008905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806015901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806015905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806015910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806016001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806016005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806016010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806016101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806016105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806016110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806033601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
42806033701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
42806033801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
42806033901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42806034101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42806034301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42806034401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42806034501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42806040001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806055212|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012|
42806056401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
42806056401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42806064810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806064910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
42806071401|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
42806071405|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
42806071501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
42806071505|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
42806072060|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42806072060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42806072101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42806072101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42806072105|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42806072105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42806072201|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42806072201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42806072205|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42806072205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42806072360|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
42806072360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
42858000101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858000101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858000101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858000201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858000201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858000201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858000301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858000301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858000301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858000401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858000401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858000401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858000501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858000501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858000501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858001101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858004001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858004001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858004001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858005501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858007545|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858007645|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858007745|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858007845|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858007945|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858008045|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858008145|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858010201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858010201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858010201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858010250|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858010250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858010250|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858010301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858010301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858010301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858010350|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858010350|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858010350|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858010401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858010401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858010401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858010450|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858010450|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858010450|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858012201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858012201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858012201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858013901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858013901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858013901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858020101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858020101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858020101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858020150|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858020150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858020150|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858020201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858020201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858020201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858020301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858020301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858020301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858020350|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858020350|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858020350|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858021501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858022501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858023401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858023401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858023401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858023450|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858023450|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858023450|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858023801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858023801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858023801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858030101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858030101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858030101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858030201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858030201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858030201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858030250|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858030250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858030250|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858030301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858030301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858030301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858030416|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858030416|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858030416|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858032501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858033801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858033801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858033801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858035340|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858035340|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858040145|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858040245|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858040345|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858040445|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858040545|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858040645|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858040745|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858041001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858041616|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858041616|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858041616|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858049340|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858049340|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858049340|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858050103|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
42858050103|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858050203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
42858050203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858051501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858051501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858051501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858058640|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858058640|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858060103|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
42858060103|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858060203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
42858060203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858061001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858063101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858063101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858063101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858072001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858072101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858072201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858072301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858072401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858072501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858072601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858072701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
42858075040|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858075040|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858075040|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858076001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858076001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858076001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858079901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858079901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858079901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858080101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858080101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858080101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858080201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858080201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858080201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858080301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858080301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858080301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858080401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858080401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858080401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858080501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858080501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858080501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858083940|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858083940|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858083940|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858090001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
42858090001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
42858090001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
42858093001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43068010102|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43068010202|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43068010402|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43068010602|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43068010802|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43068011002|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43068011202|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43068011304|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43068022001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|11/16/2021|
43068030402|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|11/16/2021|
43068030406|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|11/16/2021|
43386035101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386035105|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035105|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386035201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386035205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386035301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386035305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386035601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386035610|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035610|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386035701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386035801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386035810|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386035810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386035810|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43386040503|Nitazoxanide|https://paxpress.txpa.hidinc.com/alinia.pdf|01/31/2011|
43386040512|Nitazoxanide|https://paxpress.txpa.hidinc.com/alinia.pdf|01/31/2011|
43386048024|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386048026|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386048028|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386068001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43386068001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43386068001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43547022610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547022650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547025110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43547025110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547025210|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43547025210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547025310|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43547025310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547026510|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547026550|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547026610|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547026650|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547026710|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547026750|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547027703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547028303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547028403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547028503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547030203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547030303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547030403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547030503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547030603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547030703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547031109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547031209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547031309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547031409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547031509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547033003|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547033009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547033103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547033109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547033906|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547033950|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547034006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547034050|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547034106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547034150|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547034206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547034250|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547034306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547034350|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547034406|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547034450|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43547036009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547036909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547037009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547037310|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
43547037310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547037310|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
43547037403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547037409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547037503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547037509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547037550|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547037603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547037609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547038450|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547038510|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547038550|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547038950|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547039050|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
43547039103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547039109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547039203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547039209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547039303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547039309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547039710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547039711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547039810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547039811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547039910|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
43547039910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547039950|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
43547039950|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040010|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
43547040010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040011|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
43547040011|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040050|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
43547040050|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040550|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43547040610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040611|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43547040611|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43547040710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040711|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43547040711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040810|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43547040810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547040850|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43547040850|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43547042010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042150|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042250|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042311|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042411|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547042511|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547043506|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43547044103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547044203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547044303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43547048610|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43547048710|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43547048810|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43598003401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598003501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598003601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598003701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598013901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598013901|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012|
43598016405|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598016430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598016505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598016530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598016605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598016630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598026704|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023|
43598031330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023
43598031430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023
43598031530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/31/2024
43598031590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|01/31/2024
43598031630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023
43598031690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023
43598031730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023
43598031830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/31/2023
43598031890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/31/2023
43598031930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023
43598031990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023
43598032030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|12/31/2023
43598032130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/30/2023
43598032190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/30/2023
43598032230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023
43598032290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023
43598032330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023
43598039467|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
43598039567|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
43598043801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43598043901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43598044001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43598044101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43598047890|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
43598047990|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
43598049401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598049501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598049505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598050501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
43598050510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
43598050530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
43598055430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598055530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598055630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598055730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598055830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598055930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598057860|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
43598057901|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
43598057901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43598057930|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
43598057930|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43598058001|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
43598058001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43598058030|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
43598058030|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43598058101|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
43598058101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43598058130|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
43598058130|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43598058201|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
43598058201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43598058230|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
43598058230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43598058310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598058690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598070601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
43598073330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598073430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598074101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43598074130|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
43598074210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598074230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598074290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598074305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598074330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598074390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598074410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598074430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598074490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598074530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598074590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598081112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598081115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598082314|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598082331|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598082335|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43598084858|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598089701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019|
43598089801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019|
43598093109|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
43598093111|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
43598096530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598096630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598096730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598096830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598096930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598097030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43598097710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
43975027710|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43975027810|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43975027910|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43975028010|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43975028110|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43975028210|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
43975034903|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43975035003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43975035103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
43975035203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
44087000407|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
44087000507|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
44087000607|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
44087100502|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
44087108801|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
45802002683|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802005705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802008765|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
45802008801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802009735|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802010365|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
45802011101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802012246|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802012260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802012265|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802013326|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802014026|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802014753|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802014762|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802015065|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
45802016972|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
45802021172|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
45802026065|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
45802035165|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
45802036853|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012|
45802036862|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012|
45802039000|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
45802039001|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
45802039002|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
45802040265|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
45802041059|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
45802043321|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
45802043321|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
45802049078|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023
45802049965|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
45802062626|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802065065|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802065078|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802065087|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802068028|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802070000|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
45802070001|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
45802070002|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
45802075830|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
45802075930|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
45802084778|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802089726|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802089734|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802091939|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802091987|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802095226|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802095243|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802095301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45802097426|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45963030309|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
45963030409|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
45963030509|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
45963041806|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
45963041906|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
45963047903|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
45963048003|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
45963055511|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
45963055550|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
45963055611|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
45963055650|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
45963055711|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
45963055750|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
45963056508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45963056530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45963056608|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45963056630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45963056708|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45963056730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45963056808|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
45963056830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
46287004515|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015|
47335001083|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|11/04/2019|
47335017795|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|06/25/2019|
47335017923|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
47335027723|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
47335030888|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
47335034383|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335034483|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335053183|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47335053183|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47335053188|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47335053188|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47335053383|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47335053383|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47335053388|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47335053388|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47335053783|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47335053783|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47335053788|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47335053788|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47335058281|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
47335058381|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
47335058481|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
47335058583|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
47335060313|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
47335060313|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335060318|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
47335060318|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335060388|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
47335060388|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335060413|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
47335060413|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335060418|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
47335060418|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335060513|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
47335060513|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335060588|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
47335060588|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335060688|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
47335060688|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335063149|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335063249|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335063349|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335070349|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335070352|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335070354|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335074349|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335074649|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335075349|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335075649|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
47335075652|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
47335076783|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335077991|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47335085983|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47335085983|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335085983|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47335086083|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47335086083|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335086083|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47335086183|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47335090218|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090288|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090318|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090388|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090418|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090488|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090518|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090588|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090618|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090686|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090688|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090718|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47335090788|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
47781010444|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47781015301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47781015475|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47781019601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781019601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781019601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781019605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781019605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781019605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781022901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781022901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781022901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781022905|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781022905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781022905|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781023001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781023001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781023001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781023005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781023005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781023005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781023063|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781023063|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781023063|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781026301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781026301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781026301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781026305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781026305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781026305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781026401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781026401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781026401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781026405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781026405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781026405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781026501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781026501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781026501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781026505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781026505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781026505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781035503|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
47781035503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781035511|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
47781035511|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781035603|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
47781035603|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781035611|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
47781035611|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781035703|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
47781035703|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781035711|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
47781035711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781035803|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
47781035803|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781035811|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
47781035811|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781039260|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781039260|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781039260|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781039360|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781039360|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781039360|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781039460|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781039460|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781039460|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781039560|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781039560|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781039560|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781039660|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781039660|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781039660|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781039760|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781039760|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781039760|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781039860|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781039860|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781039860|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781042347|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
47781042347|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781042347|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781042347|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781042447|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
47781042447|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781042447|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781042447|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781042647|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
47781042647|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781042647|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781042647|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781042747|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
47781042747|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781042747|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781042747|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781042847|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
47781042847|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
47781042847|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
47781042847|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
47781058568|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47781058568|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012|
47781091401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47781091451|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
47781091601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49230064331|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
49230064551|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
49348001737|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|04/30/2024
49348001737|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|04/30/2024
49348002827|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
49348004534|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49348019609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49348054301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49348063634|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49348070609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49348070610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49348086134|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
49348086134|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
49502060561|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
49884004801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884004901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884011074|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
49884011074|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
49884011174|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
49884011174|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
49884018601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884021255|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884021374|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
49884021374|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
49884021474|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
49884021474|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
49884024801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884025011|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884025111|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884025211|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884025311|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884027711|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884030602|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
49884030602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
49884030702|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
49884030702|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
49884030802|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
49884030802|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
49884030902|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
49884030902|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
49884031002|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
49884031002|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
49884031155|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884031191|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884031555|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884031591|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884032055|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884032155|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884032255|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884032355|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884033301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884033901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884034701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884034801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884040191|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884040291|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884040391|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
49884042411|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012|
49884042511|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012|
49884042801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884043001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884054601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884054902|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
49884055402|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
49884065809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884065909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884066009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884066109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884072308|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
49884078609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884078611|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884078709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884078711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884078809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884078811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884078911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884079009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884079011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884081911|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
49884082011|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
49884083901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884084001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884084101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884084201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884084301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884084401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
49884089811|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
49884089911|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
49884098401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
49884098501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50222020310|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|05/31/2024
50222020330|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|08/31/2024
50222020360|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|08/31/2024
50222021110|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|08/31/2024
50222021130|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|08/31/2024
50222021160|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|08/31/2024
50228010901|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
50228010901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50228010905|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
50228010905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50228010910|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
50228010910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50228013630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228013690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228014601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228014605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228014610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228015660|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
50228015660|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228015701|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
50228015701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228015705|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
50228015705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228015801|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
50228015801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228015805|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
50228015805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228015960|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
50228015960|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228017701|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228017705|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228017801|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228017805|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228017901|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228017905|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228017910|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228018001|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228018005|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228018010|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228018101|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228018105|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50228032301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50228032305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50228033910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228033930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228033990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228034010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228034030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228034090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228034110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228034130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228034190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228038060|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50228038160|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50228038260|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50228038360|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50228038460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50228042360|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
50228042460|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
50228043201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228043205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228043301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228043305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228043401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228043405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228043501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228043505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228043601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228043605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228045110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228045190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228045205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228045290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228045310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228045390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228045405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228045490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50228046501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228046505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228046601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50228046605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50242000701|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|04/05/2022|
50242007401|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
50242007501|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
50242007601|Growth Hormones|https://paxpress.txpa.hidinc.com/gh.pdf|01/31/2011|
50242013801|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
50242014301|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
50268014411|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
50268014411|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50268014415|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
50268014415|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50268014511|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
50268014511|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50268014515|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
50268014515|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50268066515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50268066715|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
50268067611|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012|
50268067612|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012|
50383004004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50383004224|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50383004248|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50383004316|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50383004316|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383004316|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
50383007916|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383007916|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
50383008704|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50383008704|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383008704|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
50383008716|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50383008716|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383008716|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
50383028793|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
50383028793|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383029493|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
50383029493|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383031147|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
50383070530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
50383070530|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383074120|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50383080116|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50383080116|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
50383080416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50383080416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50383080416|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383080416|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
50383080416|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
50383092493|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
50383092493|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383093093|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
50383093093|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383096134|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
50383096134|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383096134|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
50383096430|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
50383096430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383096504|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
50383096504|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383096504|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
50383096530|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
50383096530|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50383096530|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
50419045104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50419045204|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50419045304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50419045404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50419045504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50419045604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50419045904|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50419048303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50419049104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458030001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458030006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458030206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458030503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458030611|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458030711|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458030811|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458030911|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458032001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458032006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458033001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458033006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458035001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458035006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458055001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458055101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458055201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458055401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458056001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458056101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458056201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458056301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458056401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458057501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458057710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458057718|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458057760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458057810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458057830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458057890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458057910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458057930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458057989|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458057990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458058010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458058030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458058090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458058451|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50458058501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
50458058601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
50458058701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
50458058801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
50458059601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458060601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458060701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458060801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458060901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458061101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50458061201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50474071079|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
50474071081|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
50742018921|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50742019001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50742019010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50742024760|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
50742025601|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
50742025601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
50742025601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50742025601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
50742027801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50742027901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50742063560|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50742063660|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50742063760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50742063860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50742063960|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
50742064501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
50742064501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50742064601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
50742064601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50742065601|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
50742065601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
50742065728|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50742065784|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50742065828|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50742065884|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50991012116|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50991012116|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
50991021201|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50991021401|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50991021401|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
50991022016|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50991022016|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
50991022016|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50991062601|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50991062601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50991073690|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50991074001|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50991074001|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
50991078360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
50991078490|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50991082616|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
50991082616|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
51079020820|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
51079020920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
51079021020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
51079021103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
51079028804|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079043120|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079045820|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
51079057220|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079057320|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079057420|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079057520|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079059720|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51079073320|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079073420|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079073520|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079073620|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079074920|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079078220|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
51079092120|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51079092220|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51167010602|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|02/24/2020|
51167011301|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|07/17/2018|
51167012201|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|12/04/2016|
51167020001|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|04/29/2013|
51167030001|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|04/29/2013|
51167033101|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|02/24/2020|
51167040001|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|04/29/2013|
51167050002|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|12/04/2016|
51167060001|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|04/29/2013|
51167066101|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|07/17/2018|
51167070002|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|12/04/2016|
51167080901|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|01/05/2016|
51167090001|Cystic Fibrosis Agents|https://paxpress.txpa.hidinc.com/cystic_fibrosis_agents.pdf|12/04/2016|
51224000150|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
51224000160|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
51224001050|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
51224001060|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
51224002150|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
51224002160|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
51224012150|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
51224012160|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
51224042510|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
51224042610|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
51285004001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51285004702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51285005002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51285006390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51293069601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51525590101|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
51525590101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51660014030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51660014190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51660014290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51660014390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672136307|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672138508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672138509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672207308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672209208|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672210208|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672213008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672213108|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672401601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672401701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672401801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672402701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672402703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672402801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672402803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672402901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672402903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403003|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672403601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672404201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51672404201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51672404202|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51672404202|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51672404301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51672404301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51672404302|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51672404302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51672404401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51672404401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51672404501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672404601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672405101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672405104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672405201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672405204|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672405301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672405304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672407008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672416108|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51672529601|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
51672529701|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
51862007301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51862007301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862007401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51862007401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862018501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51862018501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862018501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51862018601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51862018601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862018601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51862018701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51862018701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862018701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51862018801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51862018801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862018801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51862033201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51862033301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51862033305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51862033401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51862033405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51862034490|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
51862034590|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
51862034690|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
51862058001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51862060830|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
51862060830|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862060901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
51862061001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
51862061101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
51862061201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
51862061430|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
51862063428|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017|
51862063428|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51862063428|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862063428|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51862063528|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017|
51862063528|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51862063528|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862063528|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51862063628|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017|
51862063628|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51862063628|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862063628|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51862063728|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017|
51862063728|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51862063728|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862063728|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51862063828|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017|
51862063828|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51862063828|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862063828|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51862090001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51862090005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51862090101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51862090105|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51862090201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51862090205|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51862090301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51862090305|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51862094101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51862094101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862094105|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51862094105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862094201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51862094201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862094205|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51862094205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862094301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51862094301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51862094305|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51862094305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991007301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51991007301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991007301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51991007401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51991007401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991007401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51991007405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
51991007405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991007405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
51991033301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51991033404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51991035860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51991036060|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51991047428|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51991061150|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
51991061250|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
51991062328|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51991070401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991070405|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991070410|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991070501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991070505|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991070510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991070601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991070605|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991070610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991070701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991070705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
51991070705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
51991073520|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
51991073532|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
51991081403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51991083704|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51991083716|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51991083801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51991083810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
51991092860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
51991098101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
51991098201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
52427038290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52427038390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52427043690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52427043790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52427069203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
52427069203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52427069211|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
52427069211|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52427069403|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
52427069403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52427069411|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
52427069411|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52427069803|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
52427069803|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52427069811|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
52427069811|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52427071203|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
52427071203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52427071211|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
52427071211|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52427080390|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|02/06/2018|
52427080690|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|02/06/2018|
52536050001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/02/2023
52536051001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|05/02/2023
52817019610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52817021010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52817021050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52817023010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|06/25/2023
52817023510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
52817023530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
52817029010|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
52817029010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52817029110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
52817029110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52817029210|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
52817029210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52817029590|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|09/30/2024
52817033010|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
52817033010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52817033050|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
52817033050|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52817033110|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
52817033110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52817033200|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
52817033200|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52817033250|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
52817033250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
52856050101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52856050101|Emflaza|https://paxpress.txpa.hidinc.com/emflaza.pdf|09/24/2017|
52856050203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52856050203|Emflaza|https://paxpress.txpa.hidinc.com/emflaza.pdf|09/24/2017|
52856050303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52856050303|Emflaza|https://paxpress.txpa.hidinc.com/emflaza.pdf|09/24/2017|
52856050403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52856050403|Emflaza|https://paxpress.txpa.hidinc.com/emflaza.pdf|09/24/2017|
52856050522|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
52856050522|Emflaza|https://paxpress.txpa.hidinc.com/emflaza.pdf|09/24/2017|
52937000120|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023|
53451010101|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|02/06/2018|
53451010301|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|02/06/2018|
53489014401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53489014405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53489014410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53489014801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
53489014810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
53489014901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
53489014910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
53489015001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
53489015010|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
53489047801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53489047805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53489047901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53489047905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53489050001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
53489050601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/08/2023
53489064801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
53489064801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53489065007|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
53489065007|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746010901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746010901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746010901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746010905|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746010905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746010905|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746011001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746011001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746011001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746011005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746011005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746011005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746011701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53746011701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746011701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746011701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746014501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53746014501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746014501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746014501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746014601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53746014601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746014601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746014601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746019301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53746019401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53746019405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53746020301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746020301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746020301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746020305|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746020305|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746020305|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746020401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746020401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746020401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746020405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746020405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746020405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746044101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53746044110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53746044210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
53746052101|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
53746052110|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
53746052201|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
53746061701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746061701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746061701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746061705|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746061705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746061705|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
53746061710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
53746061710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
53746061710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
54092025290|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
54092025390|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
54092025490|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
54092025602|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
54092025702|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
54092038101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
54092038301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
54092038501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
54092038701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
54092038901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
54092039101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
54092046801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|
54092047101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|
54092047401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|
54092047701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|
54092051302|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
54092051502|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
54092051702|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
54092051902|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
54092070001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
54123011430|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
54123090730|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
54123091430|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
54123091430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
54123092930|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
54123095730|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
54123095730|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
54123098630|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
54569639900|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
54569639900|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
54766089403|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
54766089503|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
54838011540|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
54838011540|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
54838011540|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
54838013340|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
54838013340|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
54838013640|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
54838013640|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
54838013640|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
54838013670|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
54838013670|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
54838013670|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
54838050140|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
54838050280|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
54838055840|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
54838057059|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
54879000308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111012105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111012190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111012205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111012290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111012305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111012390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111012405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111012490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111016305|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111016330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111016705|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111016730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111016805|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111016830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111017001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111017005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111019705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111019730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111019790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111019805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111019830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111019890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111019905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111019930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111019990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111020005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111020030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111020090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111022905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111022990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111023005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111023090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111023105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111023190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111025660|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111025760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111025860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111025960|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111026281|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111026381|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111026481|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111026581|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
55111026805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111026830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111026890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111027405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111027490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
55111028960|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111032890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111032990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111036031|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111047801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
55111047901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
55111051930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
55111052030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
55111052130|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
55111052230|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
55111052830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
55111055131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111056330|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
55111056430|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
55111061701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
55111061901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
55111062560|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
55111062660|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
55111062930|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
55111065001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
55111067802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111067810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111067902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111067910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111068002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111068010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111068102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111068110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111068201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111068205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111068301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111068305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111068401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111068405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111069990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111070160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111072510|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
55111072530|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
55111072590|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
55111073130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111073190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111073290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111073390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111073490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111076303|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
55111078301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111078401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
55111078911|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
55111078927|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
55111079818|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
55111079835|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
55111079836|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
55111079841|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
55111079924|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
55150030901|Makena|https://paxpress.txpa.hidinc.com/makena.pdf|06/12/2015|04/07/2023
55253080130|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
55253080190|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
55253080230|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
55253080290|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
55292010401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
55513000204|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513000304|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513000404|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513000504|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513000601|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513002104|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513002304|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513002504|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513002704|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513002801|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513003201|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513005704|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513011101|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513012601|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513012610|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513013760|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
55513014401|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513014410|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513014801|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513014810|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513026701|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513026710|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513028301|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513028310|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513036955|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
55513047801|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55513047810|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
55566220000|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
55566230000|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
55566260000|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
55566270000|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
55700014730|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
55700014730|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
55700030230|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
55700030230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
55700030330|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
55700030330|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
55724021121|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|06/06/2017|
57237000201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237000205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237000299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237011901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237011999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237012701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237015430|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
57237015490|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
57237015530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
57237015590|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
57237015701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237015801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237015901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57237016805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
57237016890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
57237016990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
57237016999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
57237017090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
57237017099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
57237017105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
57237017130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
57237017190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
57237021230|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
57237021290|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
57237021330|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
57237021390|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
57237021760|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237021860|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237021905|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237021930|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237021990|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237022005|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237022030|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237022090|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237022105|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237022130|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237022190|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
57237023901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
57237024001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
57237026601|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
57237026601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664010788|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
57664010818|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
57664010888|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
57664010988|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
57664012613|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664012613|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664012613|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664012688|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664012688|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664012688|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664013388|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
57664013488|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
57664017013|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664017013|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664017013|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664017088|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664017088|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664017088|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664017613|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664017613|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664017613|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664017688|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664017688|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664017688|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664018788|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664018788|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664018788|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664021188|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
57664022388|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664022388|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664022388|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664022488|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664022488|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664022488|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664022888|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664022988|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664023088|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664024188|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
57664033688|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664033788|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664033888|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664033988|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664034088|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664034188|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664034588|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
57664034713|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
57664034788|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
57664037688|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664037708|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664037708|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664037708|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664037713|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664037713|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664037713|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664037718|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664037718|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664037718|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664037888|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664037988|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664053713|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664053713|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664053713|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664053718|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664053718|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664053718|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664053788|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
57664053788|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664053788|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
57664060688|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664060788|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664060888|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664060988|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664062188|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664062288|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664062388|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664062588|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664062688|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664062888|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664062988|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57664074513|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664074588|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664074713|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664074788|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664077283|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664077299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664077383|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664077399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664077483|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664077499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664077583|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664077599|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664078386|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
57664078386|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664078486|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
57664078486|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664078586|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
57664078586|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664078686|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
57664078686|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664078786|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
57664078786|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
57664079683|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664079699|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664079783|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664079799|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664079883|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664079899|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664079983|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664079999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664080083|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57664080099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
57841130001|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
57841130101|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
57841130103|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
57844010501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57844011001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57844011201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57844011501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57844011701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57844012001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57844013001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
57894006002|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
57894006003|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
57894006103|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
57894007001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
57894007002|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
57894007101|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
57894007102|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
57894035001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
57894064001|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
57894064011|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
58406001004|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
58406002104|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
58406003204|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
58406004401|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
58406004404|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
58406042534|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|05/31/2023
58407062530|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|03/31/2023
58407062530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2023
58468002101|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
58468004001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
58468004101|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
58468007001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
58468013001|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
58468013102|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
58657050004|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
58657050004|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
58657050004|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
58657050016|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
58657050016|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
58657050016|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
58657064501|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
58657064501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
58657064510|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
58657064510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
58657064550|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
58657064550|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
58657070001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
58657070101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
58657070201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
58657070301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
58657070310|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
58657070401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
58657070501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
58809019860|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
58809019860|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
58809055508|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
58809065150|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
58809072904|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
58809072904|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
58809085008|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
58809099901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
58809099901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59011027160|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011027160|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011027160|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011027260|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011027260|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011027260|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011027360|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011027360|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011027360|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011027460|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011027460|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011027460|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011027560|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011027560|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011027560|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011027660|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011027660|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011027660|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011027760|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011027760|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011027760|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011041010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011041010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011041010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011041010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
59011041510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011041510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011041510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011041510|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
59011042010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011042010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011042010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011042010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
59011043010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011043010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011043010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011043010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
59011044010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011044010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011044010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011044010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
59011046010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011046010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011046010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011046010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
59011048010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011048010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011048010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011048010|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
59011075004|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011075004|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011075004|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011075104|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011075104|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011075104|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011075204|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59011075204|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011075204|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011075704|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011075704|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59011075804|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59011075804|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59148000613|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148000713|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148000813|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148000913|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148001013|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148001113|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148001871|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148001971|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148003513|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148003613|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148003713|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148003813|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148003913|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148004013|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148004580|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59148007280|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59310011106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59310011406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59310012906|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59310013606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59310020006|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59310030240|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59310030480|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59310031106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59310057922|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/01/2023
59310058020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59385001201|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
59385001201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59385001230|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
59385001230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59385001401|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
59385001401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59385001430|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
59385001430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59385001601|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
59385001601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59385001630|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
59385001630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59385002160|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59385002160|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59385002260|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59385002260|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59385002360|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59385002360|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59385002460|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59385002460|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59385002560|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59385002560|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59385002660|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59385002760|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
59385002760|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
59417010110|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417010210|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417010310|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417010410|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417010510|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417010610|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417010710|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417011501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417011601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417011701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417011801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417011901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59417012001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59617001502|Allergen Extracts|https://paxpress.txpa.hidinc.com/allergen_extracts.pdf|09/01/2015|
59630075050|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59630075550|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
59651003212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59651003247|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59651004730|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
59651011055|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59651030601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59651030605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59651032930|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
59651035308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59651036001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59651036005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59651036101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59651036105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59651036201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59651036205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59651048401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59651048499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59676030201|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
59676030301|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
59676030401|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
59676031001|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
59676031002|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
59676031204|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
59676032004|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
59676034001|Erythropoiesis-Stimulating Proteins|https://paxpress.txpa.hidinc.com/esa.pdf|09/24/2013|
59746000103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746000106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746000204|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746000314|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746001032|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59746001504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746002022|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59746003022|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59746004022|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59746005022|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59746012106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746012110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746012206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746012210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746017106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746017110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746017206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746017210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746017306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746017310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746017506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746017509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746017706|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
59746017706|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59746017710|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
59746017710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59746021106|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
59746021106|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59746021110|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
59746021110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59746030632|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59746030732|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59746030832|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59746030932|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59746033310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746033990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746036030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746036190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746036290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746036390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746038206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/01/2023
59746038210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/01/2023
59746044730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746044790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746044830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746044890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746044930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59746044990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762002801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762002802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762002901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762003301|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
59762004901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762005001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762005101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762005701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762005701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762005901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762005901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762006601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762006601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762006801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762006801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762007301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762007401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762007501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762014001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2023
59762014501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762015501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762015502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762015601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762015602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762015701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762015702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762015801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762015802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762022001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2023
59762151501|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
59762151501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762151601|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
59762151601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762151603|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
59762151603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762151701|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
59762151701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762151703|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
59762151703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762151802|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
59762151802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
59762200201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59762200301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59762200401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
59762205801|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015|
59762371709|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
59762371709|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762371803|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
59762371803|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762371809|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
59762371809|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762371901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762371901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762371903|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762371903|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762371904|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762371904|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762372001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762372001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762372003|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762372003|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762372004|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762372004|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762372101|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762372101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762372103|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762372103|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762372104|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762372104|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762372201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762372201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762372203|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
59762372203|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
59762444002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762444003|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762501401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2025
59762505001|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|07/01/2023
59762600201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
59762671001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2023
59762671101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2023
59762671201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2023
59762672001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2023
59762672101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2023
59762672201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2023
59762672301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2023
59762673001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2023
59762673101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2023
59762673201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2023
59762673301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/30/2023
59922063101|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
60219167301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60219167401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60219167501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60219167601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60219167701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60219170501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60219170601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60219170607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60219170701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60219170705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60219170801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60219170805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60219204301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60219204401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60219205601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60429058611|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
60429058611|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60429058630|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
60429058630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60429058633|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
60429058633|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60429058711|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
60429058711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60429058730|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
60429058730|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60429058733|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
60429058733|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60432015004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60432015016|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60432021208|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60432024516|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60432024516|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60432027504|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
60432027504|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
60432027504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60432027516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
60432027516|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
60432027516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60432045516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
60432045516|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60432045516|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60432046608|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60432060416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
60432060416|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
60432060416|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60432060416|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
60432060616|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
60432060616|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60432060616|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60432060616|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60432060616|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
60432060816|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60432060816|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
60432070605|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60432070605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60432070605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60505003901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505004001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505004101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505010201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505011201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
60505011208|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
60505011401|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
60505011405|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
60505014708|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505016805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505016809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505016907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505016909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505017007|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505017009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505020801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505025701|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
60505025801|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
60505026101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505026301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505026401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505040405|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505040603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079200|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079204|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079300|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079400|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079600|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079800|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505079804|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505081301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60505081301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60505081301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60505083305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505084805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505132305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505132309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505252603|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
60505252703|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
60505252806|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505252906|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505253006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505253106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505255101|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
60505255105|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
60505255201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
60505255205|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
60505257808|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505257809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505257908|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505257909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505258008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505258009|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505263301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505263308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505264401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60505264401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60505264401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60505264405|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60505264405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60505264405|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60505265601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505265605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505265701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505265705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505267108|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505267109|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505267303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505267403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505267503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505267603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505267703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505283003|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505283103|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505283203|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505283303|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505283403|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505283503|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505283603|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505307503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505311003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505311008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505311108|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505311208|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505311308|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505311403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505311408|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505313001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505313008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505313201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505313208|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505313301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505313308|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505313501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505313508|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505313706|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505313901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505314003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505314008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505317007|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012|
60505327500|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505327503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505327600|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505327603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505327700|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505327703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505327800|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505327803|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
60505340909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505347803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505347903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505348303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505348403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505348803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505348903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505349203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505349303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505360303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505360309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505360403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505371309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505380709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505380809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505380909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60505384706|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
60505384706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505384801|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
60505384801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505384805|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
60505384805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505384901|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
60505384901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505384905|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
60505384905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505388207|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
60505388307|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
60505392701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505392801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505392901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505393001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
60505397206|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
60505397206|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60505397306|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
60505397306|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60505403301|Omega 3 Fatty Acids|https://paxpress.txpa.hidinc.com/lovaza.pdf|03/21/2023|
60505450209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505450309|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505450409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
60505700800|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505700800|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505700800|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505700800|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505700802|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505700802|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505700802|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505700802|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505700900|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505700900|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505700900|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505700900|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505700902|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505700902|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505700902|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505700902|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505701002|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505701002|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505701002|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505701002|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505707505|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60505707505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60505707505|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60505707605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60505707605|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60505707705|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60505707705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60505707705|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60505707805|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60505707805|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60505707905|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60505707905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60505707905|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60505708002|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505708002|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505708002|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505708002|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505708102|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505708102|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505708102|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505708102|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505708202|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505708202|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505708202|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505708202|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505708302|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505708302|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505708302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505708302|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505708402|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505708402|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505708402|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505708402|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505708502|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505708502|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505708502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505708502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505708602|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505708602|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505708602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505708602|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60505708702|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|05/19/2023
60505708702|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|05/19/2023
60505708702|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|05/19/2023
60505708702|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|05/19/2023
60574411301|Synagis|https://paxpress.txpa.hidinc.com/synagis.pdf|01/31/2011|08/31/2023
60574411401|Synagis|https://paxpress.txpa.hidinc.com/synagis.pdf|01/31/2011|09/30/2023
60631004030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60631008030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60631041230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
60687048111|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
60687048111|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60687048121|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
60687048121|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60687049211|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
60687049211|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60687049221|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
60687049221|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60687062665|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
60687062665|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60687063765|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
60687063765|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60951060270|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60951060270|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60951060270|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60951060285|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60951060285|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60951060285|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60951070070|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60951070070|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60951070070|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
60951071270|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
60951071270|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
60951071270|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
61269060510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
61269060510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
61269061010|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
61269061010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
61269062010|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
61269062010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
61442010201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
61442010210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
61442010260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
61442010301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
61442010305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
61442010310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
61442010360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
61442012610|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
61442012610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
61442012710|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
61442012710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
61442014101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
61442014110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
61442014201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
61442014210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
61442014301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
61442014310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
61570007201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
61570007301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
61570007401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
61755002002|Hyperlipidemia Agents|https://paxpress.txpa.hidinc.com/PCSK9%20Inhibitors.pdf|01/04/2017|
61755002102|Hyperlipidemia Agents|https://paxpress.txpa.hidinc.com/PCSK9%20Inhibitors.pdf|01/04/2017|
61874007560|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|02/06/2018|
61874010060|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|02/06/2018|
61874011520|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
61874011530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
61874013020|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
61874013030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
61874014530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
61874016030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
61874017008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
61958100301|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|01/31/2024
61958100401|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|01/31/2024
62037072501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
62037072601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
62037072701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
62037073401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
62135002007|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135002021|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135002046|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135002160|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
62135002160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62135002260|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
62135002260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62135002360|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
62135002360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62135005741|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135005747|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135006890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135017660|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135019122|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
62135019222|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
62135022060|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62135022060|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62135022160|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62135022160|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62135022260|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62135022260|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62135025037|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135025047|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135040012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135040112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135040212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135041590|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62135041690|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62135041890|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62135041990|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62135042090|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62135042190|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62135042290|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62135042390|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62135042490|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62135050247|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135069612|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62135076747|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62135076747|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62135076843|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62135076843|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62135091738|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135092943|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62135094947|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62135094994|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62175020432|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
62175020443|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
62175020446|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
62175020532|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
62175020543|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
62175020546|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
62175021032|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|07/09/2023
62175021043|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|07/09/2023
62175021046|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|07/09/2023
62175031037|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
62175031137|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
62175031237|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
62175031337|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
62175045232|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
62175045232|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62175045832|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
62175045832|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62175089043|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/09/2023
62175089046|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/09/2023
62175089143|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/09/2023
62175089146|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/09/2023
62175089241|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/09/2023
62175089246|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/09/2023
62175089741|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/09/2023
62175089746|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|07/09/2023
62332001931|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332001931|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332002031|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332002031|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332002730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332002790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332002791|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332002830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332002890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332002891|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332002930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332002990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332002991|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004271|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004371|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004571|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004671|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004771|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004891|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332004991|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332005030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332005090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332005091|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332005130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332005190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332005230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332005290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332006030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332006090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332007971|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332007990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008071|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008171|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008271|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008371|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332008930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332009730|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332009731|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332009830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332009831|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332009930|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332009931|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332010030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332010031|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332010130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332010131|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332010230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332010231|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332010330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332010430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332011531|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332011631|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332013130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332013230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332013290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332013330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332013390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332014060|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
62332014060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62332014131|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
62332014131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62332014171|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
62332014171|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62332014231|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
62332014231|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62332014271|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
62332014271|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62332014291|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
62332014291|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62332014360|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
62332014360|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62332014930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332014990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332015030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332015090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332015130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332015190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332019831|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332019860|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332019931|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332019960|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332020530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332020590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332020630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332020690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332020730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332020790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332020830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332020890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332020930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332021030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332021130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332021230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332021330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332021430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332021530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332034130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332034190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332034230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332034290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332034330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332034390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332036406|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332036406|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332036506|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332036506|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332036606|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332036606|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332036706|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332036706|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332036806|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332036806|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332037931|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332037931|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332038031|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332038031|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332038071|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332038071|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332038130|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332038130|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332038231|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332038231|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332038271|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62332038271|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62332038530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
62332038590|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
62332038630|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
62332038690|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
62332042631|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
62332042671|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
62332042731|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
62332042771|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
62332054460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62332058131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62332065530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62332065560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
62542030104|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
62542030104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62542030104|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62542030104|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
62542030117|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
62542030117|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62542030117|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62542030117|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
62559011107|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559011111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559013807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559015116|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
62559015116|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62559015116|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
62559016701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
62559016701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62559016701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
62559025001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559025101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559041501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559064030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559064130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559064230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559064290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559064330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559064390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559065090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559065190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559065290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559066090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559066190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559066290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559070290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|03/31/2023
62559084210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62559086015|HP Acthar|https://paxpress.txpa.hidinc.com/hp_acthar.pdf|03/08/2016|
62756013702|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
62756020201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
62756020203|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
62756020401|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
62756020403|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
62756036888|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62756036988|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62756037088|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
62756044602|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
62756044602|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62756044604|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
62756044604|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62756044605|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
62756044605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62756045983|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
62756045983|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62756046083|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
62756046083|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62756055118|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055183|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055188|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055218|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055283|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055288|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055318|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055383|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055388|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055418|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055483|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055488|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055518|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055583|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055588|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055618|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055683|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756055688|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756075164|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756075464|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756075564|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756075764|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
62756096983|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
62756096983|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62756097083|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
62756097083|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
62856040530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
62856041030|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
63004871001|HP Acthar|https://paxpress.txpa.hidinc.com/hp_acthar.pdf|03/08/2016|
63090010030|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
63304045001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63304045001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63304045001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63304045101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63304045101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63304045101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63304045201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63304045201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63304045201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63304045301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63304045301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63304045301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63304068301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63304068301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63304068301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63304068301|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
63304068401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63304068401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63304068401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63304068401|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
63304075801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63304075801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63304075801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63304082705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63304082790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63304082805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63304082890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63304082905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63304082990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63304083005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63304083090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63323016202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63323016202|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012|
63323028110|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63323047410|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63402019030|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
63402019103|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
63402019303|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
63402030230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63402030430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63402030630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63402030830|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63402031230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63402051001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63402091130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63402091164|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63459010130|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
63459020130|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
63459020530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
63459021530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
63459022030|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
63459022530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
63459050230|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
63459050230|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459050230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459050230|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459050430|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
63459050430|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459050430|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459050430|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459050630|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
63459050630|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459050630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459050630|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459050830|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
63459050830|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459050830|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459050830|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459051230|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
63459051230|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459051230|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459051230|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459051630|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|01/31/2011|
63459051630|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459051630|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459051630|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459054128|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017|
63459054128|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459054128|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459054128|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459054228|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017|
63459054228|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459054228|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459054228|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459054428|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017|
63459054428|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459054428|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459054428|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459054628|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017|
63459054628|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459054628|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459054628|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459054828|Fentanyl Agents|https://paxpress.txpa.hidinc.com/fentanyl.pdf|09/24/2017|
63459054828|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63459054828|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459054828|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63459070060|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
63459070060|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63459070160|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
63459070160|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63481062370|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63481062370|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63481062370|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63481062385|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63481062385|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63481062385|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63481062770|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63481062770|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63481062770|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63481062870|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63481062870|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63481062870|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63481062970|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
63481062970|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63481062970|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
63739000333|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
63739000333|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
63739000532|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63739021310|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
63739040310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63739048310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63739048610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63739050832|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63739052610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
63739056010|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
63739057010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63739057110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63739057210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63739057310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
63739066632|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63739067310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63739068610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63739069810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63739098832|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
63868008701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63868032550|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63868046501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63868046550|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
63868061132|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|04/01/2023
63868082354|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64011030103|Makena|https://paxpress.txpa.hidinc.com/makena.pdf|06/12/2015|04/07/2023
64380016702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380017202|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
64380017302|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
64380017402|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
64380017502|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
64380018701|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
64380018801|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
64380019701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380019801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380019901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380020001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380020101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380071206|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
64380071207|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
64380071306|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
64380071307|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
64380076111|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012|
64380078206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380078306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380078308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380078406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380078408|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380078506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380078507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380078508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380079506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380079508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380080706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380080707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380080806|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380080807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380080906|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380080907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380083506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380084206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380084306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380084307|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380093304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380093305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380093308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380093404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380093405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380093408|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380093504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380093505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380093508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380097025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380097106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64380097206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64543004404|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
64543004416|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
64543009790|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
64543009790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64543010504|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
64543010504|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
64543010504|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64543010516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
64543010516|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
64543010516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64597030160|Nuedexta|https://paxpress.txpa.hidinc.com/Nuedexta_Clin_Edit_Criteria.pdf|05/02/2017|
64764008060|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
64764012303|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
64764012530|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
64764024060|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
64764025030|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
64764025103|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
64764025303|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
64764025403|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
64764030230|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
64764030430|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
64764033560|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
64764033760|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
64764062530|DPP-4 Inhibitors|https://paxpress.txpa.hidinc.com/dpp4_inhibitor.pdf|09/25/2018|
64764080510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
64764080530|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
64896069501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896069501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896069501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896069513|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896069513|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896069513|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896069601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896069601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896069613|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896069613|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896069701|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896069701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896069701|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896069713|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896069713|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896069713|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896069801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896069801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896069801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896069813|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896069813|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896069813|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896069901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896069901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896069901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896069913|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896069913|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896069913|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896070001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896070001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896070001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896070013|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896070013|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896070013|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896070101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896070101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896070101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64896070113|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
64896070113|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64896070113|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
64980019401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/30/2023
64980019601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|11/30/2023
64980020612|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
64980022101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
64980029001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
64980029101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
64980029201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
64980029301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
64980037303|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
64980037403|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
64980037503|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
64980037603|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
64980037703|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
64980037803|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
64980037903|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
64980045303|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|05/20/2023
64980045403|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|05/20/2023
64980047201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
64980050448|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64980050924|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
64980052603|Nitazoxanide|https://paxpress.txpa.hidinc.com/alinia.pdf|01/31/2011|
64980052621|Nitazoxanide|https://paxpress.txpa.hidinc.com/alinia.pdf|01/31/2011|
64980052681|Nitazoxanide|https://paxpress.txpa.hidinc.com/alinia.pdf|01/31/2011|01/30/2024
65038028699|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/01/2021|
65038042999|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/01/2021|
65038056199|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|10/01/2021|
65162003310|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162003310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162003310|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162003416|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012|
65162004710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162004710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162004710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162004750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162004750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162004750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162004810|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162004810|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162004810|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162004910|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162004910|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162004910|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162004950|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162004950|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162004950|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162005010|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162005010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162005010|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162005110|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162005110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162005110|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162005150|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162005150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162005150|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162005703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65162005710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65162005827|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
65162010110|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65162010111|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65162010150|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65162010210|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65162010211|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65162010250|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65162010310|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65162010350|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65162011510|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162011510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162011510|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162011511|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162011511|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162011511|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162011550|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162011550|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162011550|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162012608|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162014808|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162014908|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162015008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162018810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162018850|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162018910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162018950|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162019010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162019011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162019050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162020710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162020710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162020710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162020750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162020750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162020750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162022621|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162022623|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162022808|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162023109|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
65162023309|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
65162023509|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
65162023709|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
65162024803|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
65162024903|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
65162028003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162028103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162028203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162028303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162035109|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
65162041503|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
65162041503|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162041603|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
65162041603|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162043606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162043806|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162044110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162044111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162044210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162044211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162046410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162046450|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162046510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162046550|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162046609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162046610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162046650|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162050603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162050606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162050609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162052110|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
65162052111|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
65162052210|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
65162055310|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162055610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65162055610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162055650|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65162055650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162055710|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65162055710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162055750|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65162055750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162062710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162062710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162062710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162062711|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162062711|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162062711|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162062750|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65162062750|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162062750|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65162067384|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162067684|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162068086|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
65162068086|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
65162068086|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162068086|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
65162068090|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
65162068090|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
65162068090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162068090|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
65162068312|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162068784|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65162068784|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65162069890|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65162074510|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
65162076110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076311|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076411|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076511|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076611|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162076911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162077810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162083366|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162089374|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162089603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162089609|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162089703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162089709|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162089803|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162089809|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162089903|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162089909|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162090103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162090109|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162090203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162090209|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65162091174|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162098908|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162099208|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162099308|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162099508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65162099708|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65597010130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597010330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597010430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597010530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597010630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597010730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597011030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597011130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597011230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597011330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597011430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597011530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597011630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597011730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597011830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/01/2023
65597020130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65597020230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65597020330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65649000330|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|02/06/2018|
65649015090|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|09/24/2013|
65649030103|Xifaxan|https://paxpress.txpa.hidinc.com/xifaxan.pdf|01/31/2011|
65649030302|Xifaxan|https://paxpress.txpa.hidinc.com/xifaxan.pdf|01/31/2011|
65649031112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65649055103|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|09/24/2013|
65649055204|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|09/24/2013|
65757040103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65757040203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65757040303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65757040403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65757050003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862005090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005322|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862005499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862009701|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
65862009701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862009705|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
65862009705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862013399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862013401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862013499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862015801|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
65862015801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862015901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65862016001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65862016190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862016290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862016390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862019105|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
65862019105|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862019801|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862019805|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862019899|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862019901|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862019905|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862019999|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862020001|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862020005|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862020190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862020199|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862020230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862020290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862020299|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862020330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862020390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862020399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862021401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65862021501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65862029390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862029490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862029590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862029630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862029690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862030801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862030901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862045460|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862045460|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862045560|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862045560|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862045660|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862045660|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862045760|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862045760|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862046830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862046890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862046899|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862046930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862046990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862046999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862047030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862047090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862047099|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862048901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862049001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862049101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862049301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862049460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862049501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862051205|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862051230|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862051290|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862051305|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862051330|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862051405|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862051430|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862051501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862051601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862052201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862052205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862052301|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862052305|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862052401|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862052405|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
65862052518|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862052560|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862052618|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862052660|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
65862054799|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862054890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862054899|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862054990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862054999|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862055005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862055090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862055105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862055190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862056130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056199|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056299|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056399|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056499|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056599|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056699|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862056790|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
65862056890|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
65862057030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862057190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862057290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862057390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862057490|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
65862060101|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
65862060130|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
65862060201|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
65862060230|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
65862065603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862065703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862065803|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862065903|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066105|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066205|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066305|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066405|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862066630|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862067001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862067101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862067201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862067601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862067605|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862067699|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067699|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862067701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862067705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862067799|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067799|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862067801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862067805|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067805|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862067899|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067899|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862067901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862067905|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|05/28/2015|
65862067905|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862068890|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
65862070260|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862070360|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862070460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862070560|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862070901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862070930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862073730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862073830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862073930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862074030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862074130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862074230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862074290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862074330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862074390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862077930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862077990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862078030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862078090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862078130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862078190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862080530|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
65862080630|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
65862080730|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
65862083430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862083530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862083630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862083730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862083830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862084401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862084501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862084601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862084605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862084701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862085430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862085530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862085630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862085730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862086703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862086730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862086803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862086830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862086903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862086930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862087360|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862087460|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862087560|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862087660|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862087760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
65862088060|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
65862090760|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
65862090760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862090801|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
65862090801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862090805|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
65862090805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862090901|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
65862090901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862090905|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
65862090905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862091060|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
65862091060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
65862092127|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
65862092201|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65862092201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862092201|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65862092205|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
65862092205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
65862092205|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
65862092836|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862093090|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
65862093190|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
65862094324|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862094424|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862094524|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862096701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65862096730|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65862096801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65862096901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
65862097603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862097703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862097803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
65862099830|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|02/06/2018|
66302046760|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
66490065020|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
66658010260|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
66658010560|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
66658011060|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
66658012060|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
66658020490|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
66658023001|Synagis|https://paxpress.txpa.hidinc.com/synagis.pdf|01/31/2011|
66658023101|Synagis|https://paxpress.txpa.hidinc.com/synagis.pdf|01/31/2011|
66658023407|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
66689002304|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
66689002304|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
66689002304|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
66689002316|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
66689002316|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
66689002316|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
66689002530|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
66689002530|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
66689040316|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
66689040316|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
66689040316|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
66689073505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
66758095985|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66869010490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
66869020490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
66869040490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
66993000210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993001968|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993007896|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993007996|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993008096|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993013597|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993013697|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993014130|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012|
66993014230|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012|
66993018802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993019395|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993019395|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|02/06/2018|
66993026330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993026430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993026530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993026630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993026730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993026830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993026930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993027030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993027130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993027230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993027330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993035957|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
66993042285|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
66993042385|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
66993042485|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
66993048532|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
66993058497|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993058597|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993058697|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993059402|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
66993059502|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
66993059602|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
66993059702|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
66993059802|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
66993059902|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
66993068030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
66993068130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
66993068230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
66993068330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
66993068430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
66993068530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
66993073002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993082130|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
66993082230|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
66993084435|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993084535|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
66993084635|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67253065110|Propylthiouracil|https://paxpress.txpa.hidinc.com/ptu.pdf|04/18/2011|
67386042101|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
67386042201|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
67457012410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67457042612|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67457058210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67457058304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67457058406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67457058508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67457059406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67457096701|Makena|https://paxpress.txpa.hidinc.com/makena.pdf|06/12/2015|04/07/2023
67877011601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
67877011601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
67877011601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
67877014601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
67877014601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
67877014605|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
67877014605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
67877014701|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
67877014701|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
67877014705|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
67877014705|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
67877014801|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
67877014801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
67877014930|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
67877014930|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
67877022201|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877022205|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877022210|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877022301|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877022305|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877022310|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877022401|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877022405|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877022410|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877024201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877024210|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877024601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877024610|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877024710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877024760|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877024801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877024810|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877024901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877024910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877025001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877025010|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877031901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877031905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877032001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877032005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877032030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877032050|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877032101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877032105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877032130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877032150|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877041530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877041690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877041790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877041890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877042801|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877042805|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877042901|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877042905|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
67877043003|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043105|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043205|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043305|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043405|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
67877043990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877044005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877044090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877044105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877044190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877044230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877044290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877044530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877044630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877044690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877044730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877044790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877047460|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877047560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877047750|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877048230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877048284|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877048330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877048384|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877048430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877048484|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877049930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877050030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877050130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877050230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877050730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877050790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877050830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877050890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877050930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877050990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877051030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877051090|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877051105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877051110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877051190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877051210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877051290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877051310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877051390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877051405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877051490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
67877052560|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
67877052660|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
67877057301|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
67877057305|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
67877057401|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
67877057501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
67877057505|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
67877061601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
67877061701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
67877061801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
67877062690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
67877065501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
67877065601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
67877065701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
67877065901|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
67877065901|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
67877065901|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
67877067001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
67877067001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
67877067001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
67877067101|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
67877067101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
67877067101|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
67877073101|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68001000400|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|04/19/2023
68001000501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001016100|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
68001016200|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
68001016208|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
68001016300|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
68001018000|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018008|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018100|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018103|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018200|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018300|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018400|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018408|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018500|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001018508|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001023106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001023206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001027900|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001028000|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001028006|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001028008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001028100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001028103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001028106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001028108|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001031400|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68001031500|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68001031508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68001031600|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68001031608|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68001032500|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|01/25/2024
68001032600|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|01/11/2024
68001036103|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
68001036105|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
68001036305|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
68001041100|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68001041103|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68001041200|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68001041203|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68001043592|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/26/2023
68001043594|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001043604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001043697|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001043800|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001043804|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001043896|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001043897|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001043900|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001044000|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001044004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001044998|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001045006|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001045106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001045206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001045306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001045742|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001045842|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001045942|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001046042|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001046142|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001046242|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001046342|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001046441|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001048500|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68001051106|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001051206|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001051306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001051406|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001051506|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68001052192|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001052800|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001052900|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68001052908|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68025004610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68025004710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68025006530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68025006630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68025006730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68047012016|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
68047012016|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68047012916|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
68047012916|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
68047012916|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68047014316|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
68047014316|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
68047014316|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68047018516|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
68047018516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68047018616|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
68047018616|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
68047018616|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68047070221|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68047070235|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68047070251|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68135002001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
68135010001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
68180015301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180015302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180016916|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
68180018506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180019306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180019406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180019506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180021506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180021509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180021606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180021609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180021706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180021709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180032201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68180032301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68180032401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68180033107|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180033207|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180033307|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180033407|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180037603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180037703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180037803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180039507|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68180039507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180039601|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68180039601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180039602|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68180039602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180039807|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68180039807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180039901|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68180039901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180044501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180044503|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180044601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180044603|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180044701|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180044703|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180044801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180044802|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180044901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180044902|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180044907|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180045001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180045002|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180046403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046707|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180046907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180047801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180047802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180047803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180047901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180047902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180047903|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180049001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180049101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180050101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68180050101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180050103|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68180050103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180050201|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68180050201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180050203|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68180050203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180051801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180051802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180051830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180051901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180051902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180051930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180052001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180052002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180052030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180052306|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180052406|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180053801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180060607|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68180061207|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180061307|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180061407|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180061507|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180061607|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68180063502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180063509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180063602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180063609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180063702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180063709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180063802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180063809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68180069706|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
68180069706|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68180069706|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
68180069806|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
68180069806|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68180069806|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
68180069906|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68180077901|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68180078001|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68180081942|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
68180082046|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
68180082147|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
68180082709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180082809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180096301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68180098430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68308002003|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
68308002003|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68308011501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68308014501|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
68308014501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68308014501|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
68308047547|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
68308047547|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68308047547|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
68308048047|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
68308048047|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
68308048047|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
68308070301|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68308070360|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68382004001|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
68382004101|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
68382004110|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
68382004201|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
68382005001|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68382005001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382005005|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68382005005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382005101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68382005101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382005105|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
68382005105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382007901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382007910|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382008001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382008101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382009101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
68382011205|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011214|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011305|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011314|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011405|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011414|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011505|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011514|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011614|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011705|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382011714|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382013506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382013510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382013516|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382013606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382013610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382013616|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382013706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382013710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382013716|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382020401|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68382020405|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68382020501|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68382020505|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68382024701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
68382024705|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
68382024910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382024916|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382025010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382025016|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382025110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382025116|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382025210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382025216|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68382027101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382027114|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382027201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382027301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382027314|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382047178|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382047278|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382047378|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382059101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382059201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382059301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382059401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68382072116|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382072216|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382082427|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
68382085601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382085605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382085701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382085705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382091601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382091634|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382091711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382091818|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382091911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68382095001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|06/30/2023
68382095101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|06/30/2023
68382095201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|06/30/2023
68382095301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|07/31/2023
68382095401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|07/31/2023
68382095501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|07/31/2023
68382095601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|08/31/2023
68462011233|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
68462012601|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68462012605|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68462012701|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68462012705|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
68462017801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462017901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462017905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462018801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462018805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462018901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462018905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462019001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462019005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462019030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462019505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462019590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462019605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462019690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462019705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462019790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462019805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462019890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462019913|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462019930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462020013|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462020030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462020113|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462020130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462026110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462026190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462026210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462026290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462026310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462026390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462026405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462026430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68462026530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68462026630|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68462026730|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68462026830|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68462026930|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68462027030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68462027130|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68462027501|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
68462027601|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
68462030201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462030205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462031960|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
68462032060|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
68462032130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462032230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462032290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462032330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462032430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462032501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462032560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462032590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462034690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462035594|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462038201|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68462038301|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68462038401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68462040601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462040610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462043630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462043730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462043790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462043830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462043890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462044626|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
68462044718|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
68462053435|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68462053465|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68462053494|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68462053670|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012|
68462056630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462056690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462056730|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462056790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462056830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462056890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462056930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462056990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462058340|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
68462058385|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
68462058458|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
68462058476|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
68462058576|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
68462060935|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68462060965|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68462060994|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68462065629|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462065684|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462065729|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462065784|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462065790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462071171|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462071188|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462083335|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|04/30/2023
68462083365|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|04/30/2023
68462084011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462084013|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462084111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462084113|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462084211|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462084213|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462086101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68462086201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68462086301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68462086401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68462086501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68462087801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462087805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462087830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462087901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462087905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462087930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462088001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462088005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68462088030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68546017060|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
68546017160|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
68546017260|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
68645047054|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68645051054|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68645052754|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68645055654|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68645055754|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68645055854|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68645056054|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
68645056259|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68645056354|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68645056690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68645056790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
68645058654|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68645058854|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68645059954|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68682010301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68682011001|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68682011102|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68682011203|Topical Immunomodulators|https://paxpress.txpa.hidinc.com/immunomodulators.pdf|01/31/2011|
68682027275|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012|
68682042112|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
68682042225|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
68682065020|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68682065220|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68682065520|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
68727010001|Xyrem|https://paxpress.txpa.hidinc.com/xyrem.pdf|02/17/2011|
68727035001|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|04/14/2020|10/20/2023
68727035101|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|04/14/2020|10/20/2023
68968017203|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68968017303|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68968017403|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
68968051408|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68968052508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68968341008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68968342508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68968343708|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68968345008|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68968347508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
68968555203|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68968555303|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68968555403|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
68968555503|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
69097014260|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097015807|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097015807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097015812|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097015812|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097015815|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097015815|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097015907|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097015907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097015912|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097015912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097015915|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097015915|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097016864|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097016887|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097017353|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097017364|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097031853|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097031887|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097031953|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097031987|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097032153|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097032187|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097042003|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097042003|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097042107|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097042107|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097042112|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097042112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097042207|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097042207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097042212|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097042212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097042303|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69097042303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097052444|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097052603|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
69097081307|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69097081312|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69097081507|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69097081512|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69097082502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097082507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097082515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097084053|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097084064|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097084087|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097084507|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
69097084507|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69097084607|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
69097084607|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69097084615|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
69097084615|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69097086283|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
69097093498|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
69097093598|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
69097093698|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
69097094307|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69097094312|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69097094405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097094415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097094505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097094512|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097094605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097094615|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097094705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097094712|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69097096507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097096512|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097096607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097096612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097096793|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
69097096807|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097096812|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097096907|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097096912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097097107|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097097112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097097207|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097097307|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69097097407|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69097097407|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69097097507|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69097097507|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69117002102|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69117002102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69117002103|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69117002103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69117002202|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69117002202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69117002203|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69117002203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69230020105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230030001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230030005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230030030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230030401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230030405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230030811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230030812|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230030911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230030912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230031011|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230031012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230031111|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230031112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230031611|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230031701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230031703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230032110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230032131|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230032133|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69230032212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238105401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69238105601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69238105801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69238106001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69238106201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69238112001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238115503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238115603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238115703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238115803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238120202|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
69238120202|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69238120202|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69238120302|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
69238120302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69238120302|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69238120402|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69238120402|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69238120502|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
69238120502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69238120502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69238134201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238134301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238142606|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
69238150502|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69238150502|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69238156301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
69238156401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
69238157401|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015|
69238167801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69238167901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69238168001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69238168101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69238173002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238179701|Makena|https://paxpress.txpa.hidinc.com/makena.pdf|06/12/2015|04/07/2023
69238199301|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
69238199301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69238199301|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69238205301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238212209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69238229401|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
69238229401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69238229401|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69238229401|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
69238229601|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
69238229601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69238229601|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69238229601|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
69238229801|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
69238229801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69238229801|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69238229801|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
69238230001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
69238230001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69238230001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69238230001|Oxycontin / Narcotic Analgesic|https://paxpress.txpa.hidinc.com/oxycontin.pdf|01/31/2011|
69292055001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69292058001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69292058201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69292058401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69292058601|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69292058610|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69292058801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69292059001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69315013001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69315013010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69315013101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69315013110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69315015501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69315015510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69315024812|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69315024812|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69315024812|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69315024848|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69315024848|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69315024848|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69315027520|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69315090401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69315090401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69315090405|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69315090405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69315090410|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69315090410|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69315090501|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69315090501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69315090505|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69315090505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69315090510|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69315090510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69315090601|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69315090601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69315090605|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69315090605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69315090610|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
69315090610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69339013012|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
69367013106|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69367013206|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69367013306|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69367013406|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69367013506|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69367018316|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69367018316|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367018408|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69367019760|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69367019760|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367019890|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69367019890|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
69367019901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69367019901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367021901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367021905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367021910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367023809|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367024101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367024105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367024201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367024205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367024601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367024610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367025330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69367025501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69367025505|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69367025601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69367025605|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69367027204|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69367027204|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69367027216|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69367027216|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69367028705|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
69367028709|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
69367029360|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
69367029460|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
69367030101|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69367030101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69367030105|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69367030105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69367030201|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69367030201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69367030205|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
69367030205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
69367034305|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69367034405|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69367034505|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69367034605|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69367034705|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
69452010513|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|12/31/2023
69452010519|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|12/31/2023
69452010532|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|12/31/2023
69452010613|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|12/31/2023
69452010619|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
69452010713|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
69452010719|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
69452012619|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
69452012719|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
69452014320|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69452014330|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69452014420|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69452014430|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
69452017522|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012|
69452022720|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019|
69452022820|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|12/18/2019|
69452033813|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69452034213|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
69452034313|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
69452035001|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
69543010710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69543010750|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69543013610|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|03/15/2023
69543013610|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/15/2023
69543013610|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|03/15/2023
69543013611|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|03/15/2023
69543013611|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/15/2023
69543013611|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|03/15/2023
69543013650|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|03/15/2023
69543013650|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/15/2023
69543013650|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|03/15/2023
69543025116|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|03/16/2023
69543025116|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/16/2023
69543025116|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|03/16/2023
69543025204|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|03/16/2023
69543025204|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/16/2023
69543025204|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|03/16/2023
69543025216|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|03/16/2023
69543025216|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/16/2023
69543025216|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|03/16/2023
69543025304|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|03/16/2023
69543025304|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/16/2023
69543025304|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|03/16/2023
69543038030|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038090|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038130|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038190|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038290|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038330|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038390|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038430|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038490|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038530|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038590|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69543038810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69543038810|Ketorolac|https://paxpress.txpa.hidinc.com/ketorolac.pdf|05/25/2012|
69543041210|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|03/18/2023
69543041210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|03/18/2023
69543041210|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|03/18/2023
69543041710|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
69543041710|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69543041710|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
69543042510|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69543042610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69584011110|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
69584011110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69584011190|Carisoprodol Overuse|https://paxpress.txpa.hidinc.com/soma.pdf|01/31/2011|
69584011190|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69584036110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69584036190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69584036195|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69584036210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69584061110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69584061150|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69584061210|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69584061250|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
69639010101|Antiemetic Agents|https://paxpress.txpa.hidinc.com/antiemetics.pdf|01/31/2011|
69680014395|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
69784042012|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012|
69784050001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69784050101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69784055001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
69809012605|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69809012705|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
69918010101|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
69918020101|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
69918089910|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
69918090110|Desmopressin|https://paxpress.txpa.hidinc.com/desmopressin.pdf|05/25/2012|
70000000101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000000301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000000302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000000601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000000701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|09/03/2023
70000000701|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|09/03/2023
70000000801|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000000801|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000004201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000004701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000005501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000005601|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000005601|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000005701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000005701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000009701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000012501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000012901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000012901|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000013201|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000013301|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000013301|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000013601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000013602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000013603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000014101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000015601|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000015701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000016001|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000016001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000016002|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000016002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000016201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000016202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017508|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017604|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000017605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000018101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000018701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000018701|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000018901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000018901|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000018901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000019101|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|09/03/2023
70000019102|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000019301|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000019301|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000019301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000019501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000019501|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000020102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000020103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/20/2023
70000020105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000020106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000020701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000020702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000021101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000021301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000021302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000021303|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000021304|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000021306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000021401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000021501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000023901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000025901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/13/2023
70000026101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000026201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000026301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000026302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000026401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000027801|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000027801|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000028901|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000029101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000029801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000029901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000029902|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|10/20/2023
70000030101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|09/03/2023
70000030101|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|09/03/2023
70000030201|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000030201|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000030801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/12/2023
70000030802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|10/12/2023
70000032401|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000032401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000036101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000036102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000036103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000036104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000036105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000036201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000036202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000038001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000038002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000038004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000038701|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000038701|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000038702|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|09/03/2023
70000038702|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|09/03/2023
70000046401|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000046401|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000046402|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000046402|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000047301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000047401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000047402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|09/26/2023
70000047901|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000047902|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000049101|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000049101|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000049201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000050401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000050402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000050403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000051501|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000051601|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000051602|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000051801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000051802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000052501|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000052701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000055501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000055502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000055503|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000056501|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000056501|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70000057101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000057102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000057103|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000058002|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70000058301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000058501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000058601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000059701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000059702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000060201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000060501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70000060601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70010000401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010000501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010000601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010000701|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010000801|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010000901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010001001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010001101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010001201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010001301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010001401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010001501|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010001603|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010002803|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
70010004001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010004101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010004201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010004301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70010010801|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
70010010805|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
70010010810|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
70010010901|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
70010010905|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
70010010910|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
70010011801|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
70010011805|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
70010013701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70010013705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70010013801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70010013805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70010013901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70010013905|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70010013910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70010016201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70010016305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70010075401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
70010075405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
70010077001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
70010077005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
70165000530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017|
70165001030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017|
70165001530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017|
70165002030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017|
70165002530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017|
70165003030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|01/26/2017|
70165010030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70165020030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70165030030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70199000401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70199001401|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
70199001401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
70370108001|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
70370204001|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
70370204806|VMAT2 Inhibitors|https://paxpress.txpa.hidinc.com/vmat2_inhibitor.pdf|09/25/2018|
70377000112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000114|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000115|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000212|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000214|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000215|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000312|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000314|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000315|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000412|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000414|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000415|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000512|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000514|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000515|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000613|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000712|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000713|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000812|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000813|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000912|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377000913|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377002711|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377002713|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377002811|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377002813|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377002911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377002913|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377003012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377003014|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377004512|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377004514|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377004612|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377004614|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377004712|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377004714|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377004812|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70377004813|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70436003901|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70436004001|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70436004101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70436004201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
70436009006|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
70436009106|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
70436015541|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70436015541|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70436015541|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70436015541|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
70436015542|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
70436015542|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
70436015542|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70436015542|Promethazine Utilization|https://paxpress.txpa.hidinc.com/phenergan.pdf|01/31/2011|
70505020260|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
70505020560|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
70505021060|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
70515071101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70515071201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70700014335|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70700014435|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70700014535|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70700018501|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
70709000060|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
70709000260|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
70709000560|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|11/20/2019|
70710111000|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710111001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710112901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710113001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710113101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710113201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710113301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710116100|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710116101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710116200|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710116201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710116701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710116801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710134401|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
70710134403|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
70710148801|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710148901|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710149001|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710149005|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710149101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710149105|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70710151406|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710151409|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710151506|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710151509|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710151606|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710151609|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710151706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710151709|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710175706|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710175806|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710175906|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710176006|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710176106|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710176206|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710176306|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70710183201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70748017326|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
70748017530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70748017560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70748021507|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70748021607|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70748026130|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70748026160|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
70748031209|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70748033501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70752010112|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70756042322|Lovaza|https://paxpress.txpa.hidinc.com/lovaza.pdf|07/16/2012|
70756070130|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
70756070230|GI Motility Agents|https://paxpress.txpa.hidinc.com/GImotility.pdf|01/18/2017|
70756070360|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
70756070460|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
70756081230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70756081290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70756081330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70756081390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70756081430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70756081490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70839011230|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012|
70839011230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70839012530|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012|
70839012530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70839015030|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012|
70839030030|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012|
70839031230|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012|
70839031230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70839032530|Aliskiren Containing Agents|https://paxpress.txpa.hidinc.com/aliskiren.pdf|07/16/2012|
70839032530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954001410|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70954001510|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70954001610|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70954001710|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70954005710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954005810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954005820|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954005830|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954005840|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954005910|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954005920|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954005930|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954005940|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954006010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954006020|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954006030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954006110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954008510|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
70954008520|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
70954015110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954016810|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|09/01/2015|
70954027310|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70954027410|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70954027510|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70954027520|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70954027610|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70954027620|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
70954039010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954039110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954041230|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954041330|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954041340|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954041410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954041430|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954041440|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
70954048010|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
70954048010|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
70954048110|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
70954048110|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71093011104|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
71093011105|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
71093011204|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
71093011205|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
71093012004|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
71093012005|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
71093012104|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
71093012105|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
71093012204|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
71093012205|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
71093013602|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
71093013702|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
71093013802|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
71093013902|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
71225010401|Makena|https://paxpress.txpa.hidinc.com/makena.pdf|06/12/2015|04/07/2023
71225010501|Makena|https://paxpress.txpa.hidinc.com/makena.pdf|06/12/2015|04/07/2023
71335095001|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
71335095001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335095002|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
71335095002|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335095003|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
71335095003|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335115401|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
71335115401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335115402|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
71335115402|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335115403|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
71335115403|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335116301|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
71335116301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335116302|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
71335116302|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335116303|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|12/05/2014|
71335116303|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335129601|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
71335129601|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335185801|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
71335185801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71335185802|Buprenorphine Agents|https://paxpress.txpa.hidinc.com/buprenorphine_agents.pdf|04/23/2013|
71335185802|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71376020103|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|
71376020203|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|
71376020303|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|
71376020403|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|
71376020503|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|
71904010001|Enzymes|https://paxpress.txpa.hidinc.com/enzymes.pdf|06/30/2021|
71930001912|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930001912|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930001912|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930001913|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930001913|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930001913|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930001952|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930001952|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930001952|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930002012|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930002012|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930002012|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930002052|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930002052|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930002052|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930002112|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930002112|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930002112|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930002152|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930002152|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930002152|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930002243|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930002243|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930002243|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930002330|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930002330|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930002452|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
71930002552|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
71930002643|Cough and Cold Agents|https://paxpress.txpa.hidinc.com/Cough%20&%20Cold.pdf|12/15/2015|
71930002643|Dextromethorphan Overutilization|https://paxpress.txpa.hidinc.com/dextro.pdf|07/16/2012|
71930002643|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
71930002743|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930002743|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930002743|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004212|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004212|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004212|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004252|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004252|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004252|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004312|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004312|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004312|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004352|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004352|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004352|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004412|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004412|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004412|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004452|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004452|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004452|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004512|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004512|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004512|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004552|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004552|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004552|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004612|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004612|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004612|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004652|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004652|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004652|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004712|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004712|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004712|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930004752|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930004752|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930004752|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930005412|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930005412|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930005412|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930005452|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930005452|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930005452|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930005512|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930005512|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930005512|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930005552|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930005552|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930005552|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930005612|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930005612|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930005612|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
71930005652|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
71930005652|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
71930005652|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
72060014230|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
72060014240|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
72124000101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|09/12/2023
72205000390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205000399|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205000490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205000499|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205000530|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205000590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205000599|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205002205|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205002290|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205002305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205002390|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205002405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205002490|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205002505|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205002590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205002790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72205002799|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72241002203|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
72241002203|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72241002305|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
72241002305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72241002310|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
72241002310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72241002405|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
72241002405|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72241002410|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
72241002410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
72319002102|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
72319002202|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
72485010125|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72495020105|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72495020210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72511075001|Hyperlipidemia Agents|https://paxpress.txpa.hidinc.com/PCSK9%20Inhibitors.pdf|01/04/2017|
72511076002|Hyperlipidemia Agents|https://paxpress.txpa.hidinc.com/PCSK9%20Inhibitors.pdf|01/04/2017|
72511077001|Hyperlipidemia Agents|https://paxpress.txpa.hidinc.com/PCSK9%20Inhibitors.pdf|01/04/2017|
72516001101|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
72516001201|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
72516001301|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
72516001401|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
72516001601|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|02/13/2014|
72578000506|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
72578000516|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
72578000601|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
72578000606|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
72578000616|CNS Stimulants|https://paxpress.txpa.hidinc.com/provigil.pdf|11/06/2012|
72578006414|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
72578006514|Ranexa|https://paxpress.txpa.hidinc.com/ranexa.pdf|05/25/2012|
72578009001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72578009010|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72578010606|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
72578010706|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
72606050602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72606050603|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|06/30/2023
72606050702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72606050703|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2023
72606050802|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72606050803|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2023
72606057001|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
72606057002|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
72606057003|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
72606057101|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
72606057102|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
72606057103|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
72606057201|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
72606057202|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
72606057203|Thiazolidinediones|https://paxpress.txpa.hidinc.com/thiazolidinediones.pdf|01/31/2011|
72647033101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72647033104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72786010101|Sickle Cell Disease Agents|https://paxpress.txpa.hidinc.com/sicklecell.pdf|04/05/2022|
72786011102|Sickle Cell Disease Agents|https://paxpress.txpa.hidinc.com/sicklecell.pdf|04/05/2022|
72786011103|Sickle Cell Disease Agents|https://paxpress.txpa.hidinc.com/sicklecell.pdf|04/05/2022|
72888000801|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888001200|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
72888001200|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888001201|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
72888001201|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888001205|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
72888001205|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888001301|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
72888001301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888001400|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
72888001400|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888001401|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
72888001401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888001405|Cyclobenzaprine|https://paxpress.txpa.hidinc.com/cyclobenzaprine.pdf|01/31/2011|
72888001405|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888001800|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
72888001890|PDE5-Inhibitors|https://paxpress.txpa.hidinc.com/revatio.pdf|01/31/2011|
72888002909|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72888002911|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72888007301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72888007305|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72888008000|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
72888008000|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888008000|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
72888008001|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
72888008001|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888008001|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
72888008005|Opiate Overutilization|https://paxpress.txpa.hidinc.com/opiate.pdf|11/05/2013|
72888008005|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
72888008005|Opioid Clinical Policy (MME and days supply limits)|https://paxpress.txpa.hidinc.com/opc.pdf|09/01/2020|
72888008630|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
72912052530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|07/15/2023
72912053530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|07/15/2023
72912054530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|07/15/2023
72912055530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|07/15/2023
72912057030|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|07/15/2023
72912058530|ADD/ADHD Agents|https://paxpress.txpa.hidinc.com/add_adhd_agents.pdf|09/24/2017|07/15/2023
73604091404|Cytokine and CAM Antagonists|https://paxpress.txpa.hidinc.com/cytokine.pdf|03/27/2018|
75834012929|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2023
75834013029|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|07/31/2023
75834020501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
75834020601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
75834023660|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
75834023660|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834023701|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
75834023701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834023705|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
75834023705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834023801|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
75834023801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834023805|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
75834023805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834023960|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|11/30/2023
75834023960|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|11/30/2023
75834025501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025550|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025590|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025650|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025750|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025850|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834025890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
75834026460|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
75834026560|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
75987001003|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
75987003004|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
75987003104|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
75987004005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204001055|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204001155|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204001801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204020001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204020025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204020030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204020060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204060005|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
76204060012|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
76204060030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
76204060060|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
76204070001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204070025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204080001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204080025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204090001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76204090025|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282015201|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
76282015201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
76282015210|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
76282015210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
76282015301|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
76282015301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
76282015310|COX-2 Inhibitors|https://paxpress.txpa.hidinc.com/cox2.pdf|01/31/2011|
76282015310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
76282025701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282025801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282037702|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
76282040501|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
76282040505|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
76282040590|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
76282040601|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
76282040605|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
76282040690|Gabapentin Agents|https://paxpress.txpa.hidinc.com/neurontin.pdf|01/31/2011|
76282040727|Phosphate Binders|https://paxpress.txpa.hidinc.com/phosphate_binders.pdf|01/31/2011|
76282044601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044690|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044705|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044810|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282044890|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282064038|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282064138|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76282067942|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76385011801|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76385011901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
76385012301|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
76385012350|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
76385012401|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
76385012450|Opiate/Benzodiazepine/Muscle Relaxant Combinations|https://paxpress.txpa.hidinc.com/TX%20PA_Opiate_Benzo_MRv2.pdf|03/26/2017|
76385013001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206011201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206011301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206011401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206011402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206011403|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206011404|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206011501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206011901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012301|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012302|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206012702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206013901|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206013902|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206014001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206014002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206014101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206014102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206017001|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
78206017101|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
78206017201|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
78206017202|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
78206017301|Leukotriene Modifiers|https://paxpress.txpa.hidinc.com/leukotriene.pdf|12/15/2015|
78206017401|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206017402|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206017501|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206017502|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206017601|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206017602|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206017701|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206017702|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
78206018001|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
78206018002|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
78206018101|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
78206018102|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
78206018201|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
78206018202|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
80491782503|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
80491785003|Anxiolytics and Sedative-Hypnotics|https://paxpress.txpa.hidinc.com/ash.pdf|01/31/2011|
82009000110|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009000190|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009000210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009000310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009000410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009000610|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009000710|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009000790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009000805|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009001605|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009001790|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009001990|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009002030|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/04/2016|
82009004210|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
82009004310|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
82009004410|Duplicate Therapy|https://paxpress.txpa.hidinc.com/duptherapy.pdf|02/05/2013|
90096012101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
90096012201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
90096012301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
90096012401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
90096013101|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
90096013201|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
90096013301|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
90096013401|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
90096013501|Antipsychotic Agents|https://paxpress.txpa.hidinc.com/antipsychotics.pdf|04/10/2016|
99207027028|Imiquimod|https://paxpress.txpa.hidinc.com/imiquimod.pdf|07/16/2012|